Liquidmetal (LQMT) 10-K 5 Mar 14 2013 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 04, 2014	Jun. 28, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'LIQUIDMETAL TECHNOLOGIES INC	'	'
Document Type	'10-K	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Common Stock, Shares Outstanding	'	389,302,110	'
Entity Public Float	'	'	$19,777,092
Amendment Flag	'false	'	'
Entity Central Index Key	'0001141240	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets:	'	'
Cash	$2,062	$7,162
Trade accounts receivable, net of allowance for doubtful accounts of $0 and $11	215	64
Prepaid expenses and other current assets	412	689
Total current assets	2,689	7,915
Property and equipment, net	249	161
Patents and trademarks, net	764	869
Other assets	401	28
Total assets	4,103	8,973
Current liabilities:	'	'
Accounts payable	361	154
Accrued liabilities	710	248
Accrued dividends	'	222
Convertible note, net of debt discount	'	2,365
Embedded conversion feature liability	'	3,934
Total current liabilities	1,071	6,923
Long-term liabilities	'	'
Warrant liabilities	4,921	2,766
Other long-term liabilities	856	856
Total liabilities	6,848	10,545
Shareholders' deficit:	'	'
Common stock, $0.001 par value; 700,000,000 shares authorized; 375,707,190 and 242,074,324 shares issued and outstanding at December 31, 2013 and December 31, 2012, respectively	376	242
Warrants	18,179	18,179
Additional paid-in capital	182,832	169,891
Accumulated deficit	-204,090	-189,884
Non-controlling interest in subsidiary	-42	'
Total shareholders' deficit	-2,745	-1,572
Total liabilities and shareholders' deficit	$4,103	$8,973

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, except Share data, unless otherwise specified
Allowance for doubtful accounts (in Dollars)	$0	$11
Convertible, redeemable Series A Preferred Stock, par value (in Dollars per share)	$0.00	$0.00
Convertible, redeemable Series A Preferred Stock, shares authorized	10,000,000	10,000,000
Convertible, redeemable Series A Preferred Stock, shares issued	0	506,936
Convertible, redeemable Series A Preferred Stock, shares outstanding	0	506,936
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock, shares authorized	700,000,000	700,000,000
Common stock, shares issued	375,707,190	242,074,324
Common stock, shares outstanding	375,707,190	242,074,324

Consolidated_Statements_of_Ope

Consolidated Statements of Operations and Comprehensive Income (Loss) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Revenue	'	'
Products	$1,007	$591
Licensing and royalties	19	59
Total revenue	1,026	650
Cost of revenue, products	774	354
Gross margin	252	296
Operating expenses	'	'
Selling, marketing, general and administrative	5,157	4,850
Research and development	1,156	943
Manufacturing contract costs	'	6,300
Total operating expenses	6,313	12,093
Operating loss	-6,061	-11,797
Change in value of warrants, gain (loss)	-2,155	6,547
Change in value of embedded conversion feature liability, gain	621	4,931
Debt discount amortization expense	-6,504	-11,949
Financing costs	'	-1,355
Other income	'	34
Interest expense	-245	-459
Interest income	5	23
Gain on extinguishment of debt (Note 11)	91	'
Loss before income taxes	-14,248	-14,025
Net loss and comprehensive loss	-14,248	-14,025
Net loss attributable to non-controlling interest	42	'
Net loss and comprehensive loss attributable to Liquidmetal Technologies shareholders	($14,206)	($14,025)
Net loss per common share attributable to Liquidmetal Technologies shareholders, basic (in Dollars per share)	($0.04)	($0.07)
Net loss per common share attributable to Liquidmetal Technologies shareholders, diluted (in Dollars per share)	($0.04)	($0.07)
Number of weighted average shares - basic (in Shares)	341,451,559	188,298,113
Number of weighted average shares - diluted (in Shares)	341,451,559	188,298,113

Consolidated_Statement_Of_Shar

Consolidated Statement Of Shareholders' Deficit (USD $)	Preferred Stock [Member]	Common Stock [Member]	Warrants Part of Additional Paid in Capital [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
In Thousands, except Share data
Balance at Dec. 31, 2011	$1	$130	$24,438	$149,064	($175,859)	'	($2,226)
Balance (in Shares) (in Shares) at Dec. 31, 2011	1,299,151	134,467,554	'	'	'	'	'
Conversion of Preferred Stock	-1	26	'	-25	'	'	'
Conversion of Preferred Stock (in Shares) (in Shares)	-792,215	25,669,752	'	'	'	'	'
Common stock issuance	'	83	'	13,839	'	'	13,922
Common stock issuance (in Shares) (in Shares)	'	80,171,418	'	'	'	'	'
Warrant exercises	'	1	-6,259	6,258	'	'	'
Warrant exercises (in Shares)	'	1,411,600	'	'	'	'	'
Stock option exercises	'	1	'	43	'	'	45
Stock option exercises (in Shares) (in Shares)	'	354,000	'	'	'	'	354,000
Stock-based compensation	'	'	'	53	'	'	53
Restricted stock issued to officer	'	'	'	310	'	'	310
Dividend distribution	'	'	'	349	'	'	349
Net income	'	'	'	'	-14,025	'	-14,025
Balance at Dec. 31, 2012	'	242	18,179	169,891	-189,884	'	-1,572
Balance (in Shares) (in Shares) at Dec. 31, 2012	506,936	242,074,324	'	'	'	'	'
Conversion of Preferred Stock	'	17	'	-17	'	'	222
Conversion of Preferred Stock (in Shares) (in Shares)	-506,936	16,896,070	'	'	'	'	'
Common stock issuance	'	116	'	12,137	'	'	12,253
Common stock issuance (in Shares) (in Shares)	'	116,136,796	'	'	'	'	'
Stock option exercises	'	1	'	74	'	'	75
Stock option exercises (in Shares) (in Shares)	'	600,000	'	'	'	'	600,000
Stock-based compensation	'	'	'	213	'	'	213
Restricted stock issued to officer	'	'	'	312	'	'	312
Dividend distribution	'	'	'	222	'	'	222
Net income	'	'	'	'	-14,206	-42	-14,248
Balance at Dec. 31, 2013	'	$376	$18,179	$182,832	($204,090)	($42)	($2,745)
Balance (in Shares) (in Shares) at Dec. 31, 2013	'	375,707,190	'	'	'	'	'

Consolidated_Statements_Of_Cas

Consolidated Statements Of Cash Flows (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Operating activities:	'	'
Net loss	($14,248)	($14,025)
Adjustments to reconcile net loss to net cash provided (used in) operating activities:	'	'
Depreciation and amortization	214	186
Bad debt expense	11	'
Impairment charge	'	221
Stock-based compensation	213	53
Restricted stock compensation issued to officer	312	310
Loss (Gain) from change in value of warrants	2,155	-6,547
Gain from change in value of embedded conversion feature liability	-621	-4,931
Gain on extinguishment of debt (Note 11)	-91	'
Manufacturing contract costs	'	6,300
Debt discount amortization	6,504	11,949
Non-cash interest expense	242	434
Financing costs	'	1,355
Changes in operating assets and liabilities:	'	'
Trade accounts receivable	-162	177
Prepaid expenses and other current assets	-83	-5
Other assets	'	24
Accounts payable and accrued expenses	577	-854
Deferred revenue	'	-67
Other liabilities	'	247
Net cash used in operating activities	-4,977	-5,173
Investing Activities:	'	'
Purchases of property and equipment	-185	-51
Proceeds from sale of fixed assets	1	'
Investment in patents and trademarks	-13	-35
Net cash used in investing activities	-197	-86
Financing Activities:	'	'
Proceeds from short-term debt	'	1,050
Repayment of short-term debt	'	-2,762
Payment of debt issuance costs	'	-1,033
Proceeds from exercise of stock options	74	44
Proceeds from convertible debt issuance	'	12,000
Proceeds from stock issuance	'	3,000
Net cash provided by financing activities	74	12,299
Net increase (decrease) in cash	-5,100	7,040
Cash at beginning of period	7,162	122
Cash at end of period	2,062	7,162
Supplemental Schedule of Non-Cash Investing and Financing Activities:	'	'
Offering cost in relation to common stock issuance	'	2,905
Cashless exercise of warrants	'	6,259
Pre-installment payment of convertible debt through common stock issuance	7,187	1,240
Dividends paid in common stock upon preferred stock conversion	222	'
Financing costs paid through common stock issuance	$373	'

Note_1_Description_of_Business

Note 1 - Description of Business	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block [Abstract]	'
Business Description and Basis of Presentation [Text Block]	'
	1. Description of Business
	Liquidmetal Technologies, Inc. (the “Company”) is a materials technology company that develops and commercializes products made from amorphous alloys. The Company’s family of alloys consists of a variety of bulk alloys and composites that utilizes the advantages offered by amorphous alloys technology. The Company designs, develops and sells products and components from bulk amorphous alloys to customers in various industries. The Company also partners with third-party manufacturers and licensees to develop and commercialize Liquidmetal alloy products. The Company believes that its proprietary bulk alloys are the only commercially viable bulk amorphous alloys currently available in the marketplace.
	Amorphous alloys are in general unique materials that are distinguished by their ability to retain a random atomic structure when they solidify, in contrast to the crystalline atomic structure that forms in other metals and alloys when they solidify. Liquidmetal alloys are proprietary amorphous alloys that possess a combination of performance, processing, and potential cost advantages that the Company believes will make them preferable to other materials in a variety of applications. The amorphous atomic structure of bulk alloys enables them to overcome certain performance limitations caused by inherent weaknesses in crystalline atomic structures, thus facilitating performance and processing characteristics superior in many ways to those of their crystalline counterparts. For example, in laboratory testing, zirconium-titanium Liquidmetal alloys are approximately 250% stronger than commonly used titanium alloys such as Ti-6Al-4V, but they also have some of the beneficial processing characteristics more commonly associated with plastics. The Company believes these advantages could result in Liquidmetal alloys supplanting high-performance alloys, such as titanium and stainless steel, and other incumbent materials in a wide variety of applications. Moreover, the Company believes these advantages could enable the introduction of entirely new products and applications that are not possible or commercially viable with other materials.
	The Company’s revenues are derived from i) selling bulk Liquidmetal alloy products, which include non-consumer electronic devices, medical products, automotive components, and sports and leisure goods, ii) selling tooling and prototype parts such as demonstration parts and test samples for customers with products in development: iii) product licensing and royalty revenue, and iv) research and development revenue. The Company expects that these sources of revenue will continue to significantly change the character of the Company’s revenue mix.

Note_2_Summary_of_Significant_

Note 2 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	2. Summary of Significant Accounting Policies
	Principles of Consolidation. The consolidated financial statements include the accounts of Liquidmetal Technologies, Inc. and its special-purpose wholly-owned subsidiaries, Crucible Intellectual Property and Liquidmetal Golf. All intercompany balances and transactions have been eliminated.
	Non-controlling interest. The results of operations attributable to the non-controlling interest of subsidiaries are presented within equity and are shown separately from the Company’s equity.
	Revenue Recognition. Revenue is recognized pursuant to applicable accounting standards including FASB ASC Topic 605 (“ASC 605”), Revenue Recognition. ASC 605 summarize certain points of the SEC staff’s views in applying generally accepted accounting principles to revenue recognition in financial statements and provide guidance on revenue recognition issues in the absence of authoritative literature addressing a specific arrangement or a specific industry.
	The Company’s revenue recognition policy complies with the requirements of ASC 605. Revenue is recognized when i) persuasive evidence of an arrangement exists, ii) delivery has occurred, iii) the sales price is fixed or determinable, iv) collection is probable and v) all obligations have been substantially performed pursuant to the terms of the arrangement. Revenues primarily consist of the sales and prototyping of Liquidmetal molds and bulk alloys, licensing and royalties for the use of the Liquidmetal brand and bulk Liquidmetal alloys. Revenue is deferred and included in liabilities when the Company receives cash in advance for goods not yet delivered or if the licensing term has not begun.
	License revenue arrangements in general provide for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include the grant of an exclusive or non-exclusive right to manufacture and/or sell products covered by patented technologies owned or controlled by the Company. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time.
	Licensing revenues that are one time fees upon the granting of the license are recognized when i) the license term begins in a manner consistent with the nature of the transaction and the earnings process, ii) when collectability is reasonably assured or upon receipt of an upfront fee, and iii) when all other revenue recognition criteria have been met. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the license. Licensing revenues that are related to royalties are recognized as the royalties are earned over the related period.
	Cash. The Company considers all highly liquid investments with maturity dates of three months or less when purchased to be cash equivalents. The Company limits the amount of credit exposure to each individual financial institution and places its temporary cash into investments of high credit quality with a financial institution that exceeds federally insured limits. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal. As of December 31, 2013 and 2012, the Company held no deposits in such highly liquid investments.
	Trade Accounts Receivable. The Company grants credit to its customers generally in the form of short-term trade accounts receivable. The creditworthiness of customers is evaluated prior to signing a contract with the customer. As of December 31, 2013, three customers represented 99%, or $212, of the total outstanding trade accounts receivable. As of December 31, 2012, three customers represented 96%, or $72, of the total outstanding trade accounts receivable. During 2013, there was one major customer, who accounted for 80% of the revenue. During 2012, there were three major customers, who together accounted for 70% of the revenue. In the future, the Company expects that a significant portion of the revenue may continue to be concentrated in a limited number of customers, even if the bulk alloys business grows.
	The allowance for doubtful accounts reflects management's best estimate of probable losses inherent in the trade accounts receivable.  Management primarily determines the allowance based on the aging of accounts receivable balances, historical write-off experience, customer concentrations, customer creditworthiness and current industry and economic trends.  The Company's provisions for uncollectible receivables are included in selling, marketing, general and administrative expense in the accompanying consolidated statements of operations and comprehensive loss.
	Property and Equipment. Property and equipment are stated at cost less accumulated depreciation and amortization. Additions and major renewals are capitalized. Repairs and maintenance are charged to expense as incurred. Upon disposal, the related cost and accumulated depreciation are removed from the accounts, with the resulting gain or loss included in operating income. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets, which range from one to five years.
	Intangible Assets. Intangible assets consist of the costs incurred to purchase patent rights and costs incurred to internally develop patents and trademarks. Intangible assets are reported net of accumulated amortization. Patents and trademarks are amortized using the straight-line method over a period based on their contractual lives ranging from ten to seventeen years.
	Impairment of Long-lived Assets. The Company reviews long-lived assets to be held and used in operations for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may be impaired. An impairment loss is recognized when the estimated fair value of the assets is less than the carrying value of the assets.
	Fair Value Measurements. The estimated fair values of amounts reported in the consolidated financial statements have been determined using available market information and valuation methodologies, as applicable. The fair value of cash and trade receivables, prepaid expenses and other current assets, accounts payable, and accrued liabilities approximate their carrying value due to their short maturities. The fair value of non-current assets and liabilities approximate their carrying value unless otherwise stated. The carry amounts reported for debt obligations approximate fair value due to the effective interest rate of these obligations reflecting the Company’s current borrowing rate.
	Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value based upon the following fair value hierarchy:
	Level 1 —	Quoted prices in active markets for identical assets or liabilities;
	Level 2 —	Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
	Level 3 —	Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	The Company has one Level 2 financial instrument, warrants that are recorded at fair value on a periodic basis. Warrants are evaluated under the hierarchy of FASB ASC Subtopic 480-10, FASB ASC Paragraph 815-25-1 and FASB ASC Subparagraph 815-10-15-74 addressing embedded derivatives. The fair value of such warrants is estimated using the Black-Scholes option pricing model. The foregoing warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815 (see note 12).
	The Company had one Level 3 financial instrument during the year ended December 31, 2013, that being an embedded derivative that was recorded at fair value on a periodic basis. The embedded derivative was evaluated under the hierarchy of FASB ASC Subtopic 480-10, FASB ASC Paragraph 815-25-1 and FASB ASC Subparagraph 815-10-15-74 addressing embedded derivatives. The fair value of such embedded derivative was estimated using the Monte Carlo simulation model. The foregoing embedded derivative had certain anti-dilution and exercise price reset provisions which qualified the embedded derivative to be classified as a liability under FASB ASC 815. Upon the final settlement of the Senior Convertible Notes, this liability was extinguished as the underlying conversion option had been executed. As such, the fair value of the liability was reduced to zero upon conversion (see note 11).
	As of December 31, 2013, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:
			Fair Value		Level 1		Level 2		Level 3
	Warrant liabilities			-		-		4,921		-
	Research and Development Expenses. Research and development expenses represent salaries, related benefits expense, expenses incurred for the design and testing of new processing methods and other expenses related to the research and development of Liquidmetal alloys. Development costs incurred in research and development activities are expensed as incurred.
	Advertising and Promotion Expenses. Advertising and promotion expenses are expensed when incurred. Advertising and promotion expenses were $78 and $41, for the years ended December 31, 2013 and 2012, respectively.
	Legal Costs. Legal costs are expensed as incurred.
	Stock-Based Compensation. The Company accounts for share-based compensation in accordance with the fair value recognition provisions of FASB ASC Topic 718, Share-based Payment, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated financial statements based on their fair values. The fair value of stock options is calculated by using the Black-Scholes option pricing formula that requires estimates for expected volatility, expected dividends, the risk-free interest rate and the term of the option. If any of the assumptions used in the Black-Scholes model change significantly, share-based compensation expense may differ materially in the future from that recorded in the current period.
	Income Taxes. Income taxes are provided under the asset and liability method as required by FASB ASC Topic 740, Accounting for Income Taxes. Under this method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax basis of existing assets and liabilities. The effect of a tax rate change on deferred taxes is recognized in operations in the period that the change in the rate is enacted. Valuation allowances are established when necessary to reduce net deferred tax assets to the amount expected to be realized. Under the provision of FASB ASC Topic 740, the Company had no material unrecognized tax benefits and no adjustments to liabilities or operations were required. The Company may recognize interest and penalties related to uncertain tax positions in income tax expense. There was no expense related to interest and penalties for the year ended December 31, 2013 and 2012.
	Earnings Per Share. Basic earnings per share (“EPS”) is computed by dividing earnings (losses) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.
	Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates. These management estimates are primarily related to impairment of long-lived assets, allowance for bad debt account balances, and warrant valuation.
	Subsequent Events. In May 2009, the FASB issued a new accounting standard which established general accounting standards and disclosure for subsequent events. In accordance with this standard, the Company evaluated subsequent events through the filing of its Annual Report on Form 10-K with the SEC.
	Recent Accounting Pronouncements.
	Offsetting Assets and Liabilities
	In December 2011 and December 2012, the FASB issued accounting standards updates modifying the disclosure requirements about the nature of an entity's rights of offsetting assets and liabilities in the consolidated balance sheet under master netting agreements and related arrangements associated with financial and derivative instruments. The guidance requires increased disclosure of the gross and net recognized assets and liabilities, collateral positions and narrative descriptions of setoff rights. The adoption of this pronouncement did not have a material impact on the Company’s Consolidated Financial Statements and accompanying disclosures.
	Presentation of Items Reclassified out of Accumulated Other Comprehensive Income
	In February 2013, the FASB issued an accounting standards update which requires disclosure related to items reclassified out of accumulated other comprehensive income (AOCI). The guidance requires entities to present separately, for each component of other comprehensive income (OCI), current period reclassifications and the remainder of the current-period OCI. In addition, for certain current period reclassifications, an entity is required to disclose the effect of the item reclassified out of AOCI on the respective line item of net income. The adoption of this pronouncement did not have a material impact on the Company’s Consolidated Financial Statements and accompanying disclosures.
	Joint and Several Liabilities
	In February 2013, the FASB issued an accounting standard update which modifies the requirements for the recognition, measurement, and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation is fixed at the reporting date. The guidance requires companies to measure these obligations as the sum of the amount the company has agreed with co-obligors to pay and any additional amount it expects to pay on behalf of one or more co-obligors. This guidance is effective for all fiscal years, and interim periods within those years, beginning after December 31, 2013. The Company does not expect this guidance to have a material impact on the Company’s Consolidated Financial Statements.
	Presentation of Unrecognized Tax Benefits
	In July 2013, the FASB issued an accounting standards update which will require that an unrecognized tax benefit be presented on the balance sheet as a reduction of a deferred tax asset for a net operating loss ("NOL") or tax credit carryforward under certain circumstances. The guidance is effective for all fiscal years, and interim periods within those years, beginning December 15, 2013.  The Company does not expect this guidance to have a material impact on the Company’s Consolidated Financial Statements.

Note_3_Significant_Transaction

Note 3 - Significant Transactions	12 Months Ended
	Dec. 31, 2013
Significant Transactions [Abstract]	'
Significant Transactions [Text Block]	'
	3. Significant Transactions
	2013 Stock Purchase Agreement
	On November 8, 2013, the Company entered into a Common Stock Purchase Agreement (the “2013 Purchase Agreement”) with Kingsbrook Opportunities Master Fund LP, Tech Opportunities LLC, and Iroquois Master Fund Ltd. (each, a “2013 Selling Stockholder” and collectively, the “2013 Selling Stockholders”). The 2013 Purchase Agreement provides that, upon the terms and subject to the conditions set forth therein, each of the 2013 Selling Stockholders has committed to purchase such 2013 Selling Stockholders’ pro rata portion of up to $20.0 million (the “Total Commitment”) worth of the Company’s common stock, $0.001 par value (the “Shares”), over the 36-month term of the 2013 Purchase Agreement.
	In consideration for the 2013 Selling Stockholders' execution and delivery of the 2013 Purchase Agreement, on November 8, 2013, the Company delivered irrevocable instructions to its transfer agent to issue to each 2013 Selling Stockholder, not later than 4:00 p.m. (New York City time) on the second trading day immediately following November 8, 2013, certificates representing such 2013 Selling Stockholder’s pro rata portion of 2,666,667 shares of common stock (the “Commitment Shares”). The Commitment Shares are being registered for resale, together with the shares that may be purchased under the 2013 Purchase Agreement.
	From time to time over the term of the 2013 Purchase Agreement, the Company may, at its sole discretion, provide each of the 2013 Selling Stockholders with draw down notices (each a “Draw Down Notice”) to purchase a specified dollar amount of Shares (the “Draw Down Amount”) over a five (5) consecutive trading day period commencing on the trading day specified in the applicable Draw Down Notice (the “Pricing Period”) with each draw down subject to the limitations discussed below. The maximum amount of Shares requested to be purchased pursuant to any single Draw Down Notice cannot exceed a dollar amount equal to the lesser of (i) 300% of the average trading volume of the Company’s common stock during the ten (10) trading days immediately preceding the date the applicable Draw Down Notice is delivered (the “Applicable Draw Down Exercise Date”) multiplied by the lower of (A) the closing trade price of the Company’s common stock on the trading day immediately preceding the Applicable Draw Down Exercise Date and (B) the average of the closing trade prices of our common stock for the three (3) trading days immediately preceding the Applicable Draw Down Exercise Date (such lower price, the “Reference Price”), and (ii) a specified dollar amount set forth in the 2013 Purchase Agreement based on the Reference Price as of the Applicable Draw Down Exercise Date.
	Once presented with a Draw Down Notice, each of the 2013 Selling Stockholders is required to purchase such 2013 Selling Stockholder’s pro rata portion of the applicable Draw Down Amount on each trading day during the applicable Pricing Period on which the daily volume weighted average price for the Company’s common stock (the “VWAP”) equals or exceeds an applicable floor price equal to the product of (i) 0.775 and (ii) the Reference Price, subject to adjustment (the “Floor Price”), provided that in no event shall the Floor Price be less than $0.03875. If the VWAP falls below the applicable Floor Price on any trading day during the applicable Pricing Period, the 2013 Purchase Agreement provides that the 2013 Selling Stockholders will not be required to purchase their pro rata portions of the applicable Draw Down Amount allocated to that trading day. The per share purchase price for the Shares subject to a Draw Down Notice shall be equal to 90% of the lowest daily VWAP that equals or exceeds the applicable Floor Price during the applicable Pricing Period. Each purchase pursuant to a draw down shall reduce, on a dollar-for-dollar basis, the Total Commitment under the 2013 Purchase Agreement.
	The Company is prohibited from issuing a Draw Down Notice if (i) the amount requested in such Draw Down Notice exceeds the Maximum Draw Down Amount, (ii) the sale of Shares pursuant to such Draw Down Notice would cause the Company to issue or sell or the 2013 Selling Stockholders to acquire or purchase an aggregate dollar value of Shares that would exceed the Total Commitment, (iii) the sale of Shares pursuant to the Draw Down Notice would cause the Company to sell or the 2013 Selling Stockholders to purchase an aggregate number of shares of the Company’s common stock which would result in the collective beneficial ownership by the 2013 Selling Stockholders of more than 9.99% of the Company’s common stock (as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder), or (iv) the applicable Floor Price would be less than $0.03875 on the Applicable Draw Down Exercise Date. The Company cannot make more than one draw down in any Pricing Period and must allow two (2) trading days to elapse between the completion of the settlement of any one draw down and the commencement of a Pricing Period for any other draw down.
	On February 11, 2014 an initial registration statement, covering 96,555,893 shares to be issued under the Stock Purchase agreement, was declared effective by the SEC.
	No draw-downs were made under the 2013 Stock Purchase Agreement during 2013. During 2014, as of the filing date of this report, the Company has received an aggregate of $3,000 under the 2013 Stock Purchase Agreement through the issuance of 13,292,020 share of its common stock.
	July 2012 Private Placement
	On July 2, 2012, the Company entered into a private placement transaction (the “July 2012 Private Placement”) pursuant to which the Company issued $12,000 in principal amount of senior convertible notes that were due on September 1, 2013. The notes were convertible into shares of the Company’s common stock at a conversion price of $0.352 per share. The notes bore interest at 8% per annum and were payable in twelve equal monthly installments of principal and interest beginning on October 1, 2012. Each monthly installment payment may have been made in cash, shares of the Company’s common stock, or a combination thereof. If paid in shares, such shares were valued at the lower of (i) the then applicable conversion price or (ii) a price that was 87.5% of the arithmetic average of the ten (or in some cases fewer) lowest weighted average prices of the Company’s common stock during the twenty trading day period ending two trading days before the payment date or the date on which the Company elected to pay in shares, whichever was lower. As of July 17, 2013, the Company had issued 163,641,547 shares of common stock in full satisfaction of notes.
	As a part of the July 2012 Private Placement, the Company issued warrants to purchase 18,750,000 shares of the Company’s common stock at an exercise price of $0.384 per share, and such warrants first became exercisable on January 2, 2013, which was six months after the issuance date thereof. In the event that the Company were to issue or sell shares of their common stock at a price per share that is less than the exercise price then in effect, the exercise price of the warrants will be reduced based on a weighted-average formula. In addition, on the two year anniversary of the issuance date, the then applicable exercise price will be reset to equal the lesser of (i) the then current exercise price or (ii) 87.5% of the arithmetic average of the ten lowest weighted average prices of the common stock during the twenty trading day period ending two trading days immediately preceding the reset date. All of the warrants will expire on July 2, 2017.
	June 2012 Visser MTA Agreement
	On June 1, 2012, the Company entered into a Master Transaction Agreement (the “Visser MTA Agreement”) with Visser Precision Cast, LLC (“Visser”) relating to a strategic transaction for manufacturing services and financing.
	Under the manufacturing and service component of the Visser MTA Agreement, the Company agreed to engage Visser as a perpetual, exclusive manufacturer of non-consumer electronic products and to not, directly or indirectly, conduct manufacturing operations, subcontract for the manufacture of products or components or grant a license to any other party to conduct manufacturing operations, except for certain limited exceptions. Further, the Company agreed to sublicense to Visser, on a fully-paid up, royalty-free, irrevocable, perpetual, worldwide basis, all intellectual property rights held by the Company. Visser’s use of such sublicense is limited to the exercise of its manufacturing rights, provided that such limitation will terminate if the Company were to fail to comply with certain technical, administrative, and research and development support obligations set forth in the transaction agreements with Visser and such failure is not cured within 60 days. In addition, Visser has a right of first refusal over any proposed transfer of the Company’s technology pursuant to any license, sublicense, sale or other transfer, other than a license to a machine or alloy vendor.
	Under the financing component of the Visser MTA Agreement, the Company issued and sold to Visser in a private placement transaction (i) 30,000,000 shares of common stock at a purchase price of $0.10 per share resulting in proceeds of $3,000, (ii) warrants to purchase 15,000,000 shares of common stock (subsequently increased to 18,539,762 shares under the anti-dilution provision of the warrants, see note 12) at an exercise price of $0.22 per share (subsequently reduced to $0.18 per share under the anti-dilution provision of the warrants) which expire on June 1, 2017 and (iii) a secured convertible promissory note (the “Promissory Note”) in the aggregate principal amount of up to $2,000 which was convertible into shares of common stock at a conversion rate of $0.22 per share. The Promissory Note was issued pursuant to a $2,000 loan facility made available by Visser, but no borrowings were made by us under this loan facility, as the deadline for making borrowings under the facility expired on November 15, 2012. All of the shares of common stock issuable upon exercise of the warrants are subject to a lock-up period through December 31, 2016.
	The warrants under the Visser MTA Agreement contain certain anti-dilution and exercise price reset provisions which results in liability accounting under FASB ASC 815 (see note 12).  In relation to the financing cost component to the Visser transaction, the Company performed a prorated allocation of the fair value of the warrants on the convertible promissory note and the common stock based on their relative fair values. The Company capitalized deferred financing costs in relation to the convertible promissory note totaling $1,355 and offset additional paid-in capital for $2,905 in relation to the warrants. The Company assessed the value of the deferred financing costs as of the quarter ended June 30, 2012 and determined that the value was impaired due to the limitations on the Company’s ability to request for advances as discussed above. Therefore, the Company expensed the deferred financing costs totaling $1,355 as of the quarter ended June 30, 2012.
	In connection with the Visser MTA Agreement, the Company performed a valuation analysis of the manufacturing service and financing components of the Visser MTA Agreement as part of the bundled contract. The Company has assessed and determined that while these components may have market values on a standalone basis, the values of the manufacturing component and sublicense component were deemed immaterial for accounting purposes. Further, the Company’s weighted average market stock price was approximately $0.31 per share at the time of share issuances to Visser. As the actual share purchase price related to the financing component of the Visser MTA Agreement was $0.10 per share, the $0.21 per share difference was treated as manufacturing contract costs and $6,300 was expensed as operating expenses during the second quarter ended June 30, 2012.
	On January 17, 2012, February 27, 2012, March 28, 2012 and April 25, 2012, the Company issued 8% unsecured, bridge promissory notes to Visser that were due upon demand in the amounts of $200, $200, $350 and $300, respectively. The aggregate principal amount of $1,050 and accrued interest under the bridge promissory notes were all paid off on June 1, 2012 by utilizing a portion of the proceeds received under the financing component of the Visser MTA Agreement.
	In November 2013, the Company and Visser entered into arbitration proceedings to resolve disputes associated with the Visser MTA Agreement.
	Apple License Transaction
	On August 5, 2010, the Company entered into a license transaction with Apple Inc. (“Apple”) pursuant to which (i) the Company contributed substantially all of its intellectual property assets to a newly organized special-purpose, wholly-owned subsidiary, called Crucible Intellectual Property, LLC (“CIP”), (ii) CIP granted to Apple a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in the field of consumer electronic products, as defined in the license agreement, in exchange for a license fee, and (iii) CIP granted back to the Company a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in all other fields of use. Additionally, in connection with the license transaction, Apple required the Company to complete a statement of work related to the exchange of Liquidmetal intellectual property information. The Company recognized a portion of the one-time license fee upon receipt of the initial payment and completion of the foregoing requirements under the license transaction. The remaining portion of the one-time license fee was recognized at the completion of the required statement of work.
	Under the agreements relating to the license transaction with Apple, the Company is obligated to contribute all intellectual property that it developed through February 2012. Subsequently, the Company amended the Capture Period to extend through February 2014. The Company is also obligated to maintain certain limited liability company formalities with respect to CIP at all times after the closing of the license transaction.
	Other License Transactions
	On January 31, 2012, the Company and Engel Austria Gmbh (“Engel”) entered into a Supply and License Agreement for a five year term whereby Engel was granted a non-exclusive license to manufacture and sell injection molding machines to the Company’s licensees. Since that time, we and Engel have agreed on an injection molding machine configuration that can be commercially supplied and supported by Engel.  On December 6, 2013, the companies entered into an Exclusive License Agreement for a 10 year term whereby Engel was granted an exclusive license to manufacture and sell injection molding machines to our licensees in exchange for certain royalties to be paid by Engel to us based on a percentage of the net sales price of injection molding machines.
	On November 16, 2011, the Company entered into a Development Agreement with Materion Brush Inc. (“Materion”) to evaluate, analyze and develop amorphous alloy feedstock to be supplied in commercial quantities.  Further, on June 17, 2012, the Company entered into a Sales Representation Agreement with Materion whereby Materion shall promote the sale of the Company’s products for certain commissions.  This agreement is for a two year initial term with annual, automatic renewals. To date, there have been no commission payments related to this agreement.
	The Company’s Liquidmetal Golf subsidiary has the exclusive right and license to utilize the Company’s Liquidmetal alloy technology for purposes of golf equipment applications. This right and license is set forth in an intercompany license agreement between Liquidmetal Technologies and Liquidmetal Golf. This license agreement provides that Liquidmetal Golf has a perpetual and exclusive license to use Liquidmetal alloy technology for the purpose of manufacturing, marketing, and selling golf club components and other products used in the sport of golf. Liquidmetal Technologies owns 79% of the outstanding common stock in Liquidmetal Golf.
	In June 2003, the Company entered into an exclusive license agreement with LLPG, Inc. (“LLPG”).  Under the terms of the agreement, LLPG has the right to commercialize Liquidmetal alloys, particularly precious-metal based compositions, in jewelry and high-end luxury product markets.  The Company, in turn, will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by LLPG. The exclusive license agreement with LLPG expires on December 31, 2021.
	In March 2009, the Company entered into a license agreement with Swatch Group, Ltd. (“Swatch”) under which Swatch was granted a perpetual non-exclusive license to the Company’s technology to produce and market watches and certain other luxury products. In March 2011, this license agreement was amended to grant Swatch exclusive rights as to watches, and the Company’s license agreement with LLPG was simultaneously amended to exclude watches from LLPG’s rights. The Company will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by Swatch. The license agreement with Swatch will expire on the expiration date of the last licensed patent.

Note_4_Liquidity_and_Going_Con

Note 4 - Liquidity and Going Concern Issues	12 Months Ended
	Dec. 31, 2013
Liquidityand Going Concern Issues [Abstract]	'
Liquidityand Going Concern Issues [Text Block]	'
	4. Liquidity and Going Concern Issues
	The Company’s cash used in operations was $4,977 for the year ended December 31, 2013, while cash used in operations was $5,173 for the year ended December 31, 2012.  The Company’s cash used in investing activities was $197 for the year ended December 31, 2013 primarily from purchase of property and equipment. The Company’s cash provided by financing activities was $74 for the year ended December 31, 2013 primarily from proceeds from stock option exercises. As of December 31, 2013, the Company’s cash balance was $2,062.
	On July 2, 2012, the Company entered into definitive agreements relating to a private placement of $12,000 in principal amount of Senior Convertible Notes due on September 1, 2013 and Warrants to the purchasers of such Convertible Notes giving such purchasers the right to purchase up to an aggregate of 18,750,000 shares of the Company’s common stock at an exercise price of $0.384 per share. As of July 17, 2013, the notes under the July 2012 Private Placement were paid off in full through issuance of common stock (see note 11).
	On November 8, 2013, the Company entered into the 2013 Stock Purchase Agreement that will allow it to raise up to $20 million through periodic issuances of common stock over a three year period. On February 11, 2014 an initial registration statement, covering 96,555,893 shares to be issued under the Stock Purchase agreement, was declared effective by the SEC.
	The Company anticipates that its current capital resources, when considering expected losses from operations, will be sufficient to fund the Company’s operations through the end of March 2014. The Company has a relatively limited history of producing bulk amorphous alloy components and products on a mass-production scale. Furthermore, Visser’s ability to produce the Company’s products in desired quantities and at commercially reasonable prices is uncertain and is dependent on a variety of factors that are outside of the Company’s control, including the nature and design of the component, the customer’s specifications, and required delivery timelines. Such factors will likely require that the Company draw down on the 2013 Stock Purchase Agreement or raise additional funds by other means to support its operations beyond the first quarter of 2014. There is no assurance that the Company will be able to draw down on the 2013 Stock Purchase Agreement or raise additional funds by other means on acceptable terms, if at all. If the Company were to draw down on the 2013 Stock Purchase Agreement or raise additional funds through other means by issuing securities, existing stockholders may be diluted. If funding is insufficient at any time in the future, the Company may be required to alter or reduce the scope of its operations or to cease operations entirely. Uncertainty as to the outcome of these factors raises substantial doubt about the Company’s ability to continue as a going concern.
	No draw downs were made under the 2013 Stock Purchase Agreement during 2013. During 2014, as of the filing date of this report, the Company has received an aggregate of $3,000 under the 2013 Stock Purchase Agreement through the issuance of 13,292,020 shares of its common stock.

Note_5_Trade_accounts_receivab

Note 5 - Trade accounts receivable	12 Months Ended
	Dec. 31, 2013
Receivables [Abstract]	'
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	'
	5. Trade accounts receivable
	Trade accounts receivable from continuing operations were comprised of the following:
		December 31,
		2013		2012
	Trade accounts receivable	$	215	$	75
	Less: Allowance for doubtful accounts		-		(11	)
	Trade accounts receivable, net	$	215	$	64

Note_6_Prepaid_Expenses_and_Ot

Note 6 - Prepaid Expenses and Other Current Assets	12 Months Ended
	Dec. 31, 2013
Prepaid Expenses And Other Current Assets [Abstract]	'
Prepaid Expenses And Other Current Assets [Text Block]	'
	6. Prepaid Expenses and Other Current Assets
	Prepaid expenses and other current assets totaled $412 and $689 as of December 31, 2013 and December 31, 2012, respectively and primarily consists of prepaid invoices and insurance premiums that will be reclassified to expense as shipments are made to customers or services are provided. Deferred debt issuance costs are also included in prepaid expenses and other current assets and were $0 and $399 as of December 31, 2013 and 2012, respectively. The balance attributed to deferred financing costs was reduced to zero during 2013 as a result of $360 of amortization expense and $39 written off as a result of the extinguishment of the senior convertible notes (see note 11).

Note_7_Property_and_Equipment

Note 7 - Property and Equipment	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	7. Property and Equipment
	Property and equipment consist of the following:
		December 31,
		2013			2012
	Machinery and equipment	$	1,107		$	1,098
	Computer equipment		203			118
	Office equipment, furnishings, and improvements		277			190
	Total		1,587			1,406
	Accumulated depreciation		(1,338	)		(1,245	)
	Total property and equipment, net	$	249		$	161
	Depreciation expense for the years ended December 31, 2013 and 2012 were $96 and $52, respectively and is included in selling, marketing and general and administrative expense in the consolidated statements of operations and comprehensive loss.

Note_8_Patents_and_Trademarks_

Note 8 - Patents and Trademarks, net	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block [Abstract]	'
Intangible Assets Disclosure [Text Block]	'
	8. Patents and trademarks, net
	Patents and trademarks consist of the following:
		December 31,
		2013			2012
	Purchased and licensed patent rights	$	566		$	566
	Internally developed patents		1,664			1,664
	Trademarks		139			126
	Total		2,369			2,356
	Accumulated amortization	$	(1,605	)	$	(1,487	)
	Total intangible assets, net	$	764		$	869
	Amortization expense was $118 and $137 for the years ended December 31, 2013 and 2012, respectively. The estimated aggregate amortization expense for each of the five succeeding years is as follows:
	December 31,	Aggregate Amortization Expense
	2014		103
	2015		97
	2016		95
	2017		84
	2018		83
	Thereafter		302
	Accumulated amortization for the years ended December 31, 2013 and 2012 is as follows:
		December 31,
		2013			2012
	Purchased and licensed patent rights	$	(483	)	$	(457	)
	Internally developed patents		(1,022	)		(937	)
	Trademarks		(100	)		(93	)
	Total	$	(1,605	)	$	(1,487	)
	The weighted average amortization periods for the years ended December 31, 2013 and 2012 are as follows:
		December 31,
		2013			2012
	Purchased and licensed patent rights		17			17
	Internally developed patents		17			17
	Trademarks		10			10
	Purchased patent rights represent the exclusive right to commercialize the bulk amorphous alloy and other amorphous alloy technology acquired from California Institute of Technology (“Caltech”), through a license agreement with Caltech and other institutions. All fees and other amounts payable by the Company for these rights and licenses have been paid or accrued in full, and no further royalties, license fees or other amounts will be payable in the future under the license agreements.
	In addition to the purchased and licensed patents, the Company has internally developed patents. Internally developed patents include legal and registration costs incurred to obtain the respective patents. The Company currently holds various patents and numerous pending patent applications in the United States, as well as numerous foreign counterparts to these patents outside of the United States.

Note_9_Other_LongTerm_Liabilit

Note 9 - Other Long-Term Liabilities	12 Months Ended
	Dec. 31, 2013
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]	'
Other Liabilities Disclosure [Text Block]	'
	9. Other Long-Term Liabilities
	Other Long-term Liabilities balance of $856 and $856 as of December 31, 2013 and 2012, respectively, consists of long term, aged payables to vendors, individuals, and other third parties that have been outstanding for more than 5 years. The Company is in the process of researching and resolving the balances for settlement and/or write-off in accordance with applicable accounting rules.

Note_10_ShortTerm_Debt

Note 10 - Short-Term Debt	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block [Abstract]	'
Short-term Debt [Text Block]	'
	10. Short-term debt
	On August 6, 2010, SAGA, SpA in Padova, Italy (“SAGA”), a specialist parts manufacturer, filed a litigation case against the Company claiming damages of $3,200 for payment on an alleged loan and for alleged breach of contract in connection with the formation of joint venture called Liquidmetal SAGA Italy, Srl (“LSI”). On April 6, 2011 (the “Effective Date”), the Company entered into a Settlement and Equity Interest Purchase Agreement with SAGA pursuant to which (i) the joint venture between the Company and SAGA was terminated, (ii) the Company and SAGA both agreed to cause certain pending legal action against each other to be dismissed with prejudice, (iii) the Company paid SAGA $2,800 in the form of 4,496,429 restricted shares (“Shares”) of the Company’s common stock in exchange for SAGA’s equity interest in LSI, and (iv) the Liquidmetal technology license to LSI was terminated.
	The number of Shares issued to SAGA on the Effective Date was based on the 30 day trailing, volume weighted average price of the Company’s stock as of the Effective Date. An additional provision of the SAGA Settlement and Equity Interest Purchase Agreement was the obligation of the Company to issue a promissory note to compensate for a decrease in the market price of the Company’s common stock over a six month period from the Effective Date of the settlement. On October 10, 2011, the Company issued to SAGA a promissory note in the principal amount of $1,712 due October 10, 2012, bearing interest of 8% per annum, to account for the decrease in the market price of the Company’s common stock. The $1,712 principal amount of the note was included in Short Term Debt in the Company’s consolidated balance sheet as of December 31, 2011.
	On July 11, 2012, the Company paid $1,743 to SAGA and paid off all amounts owed under the SAGA promissory note. Interest expense related to the promissory note for the year ended December 31, 2012 was $68. No expense was recorded under this obligation during 2013.
	On January 17, 2012, February 27, 2012, March 28, 2012 and April 25, 2012, the Company issued 8% unsecured, bridge promissory notes to Visser that were due upon demand in the amount of $200, $200, $350 and $300, respectively. The aggregate principal amount of $1,050 and accrued interest under the bridge promissory notes were all paid off on June 1, 2012 by utilizing a portion of the proceeds received under the financing component of the Visser MTA Agreement (see note 3). Interest expense on the bridge promissory notes was $18 for the year ended December 31, 2012. No expense was recorded under these obligations during 2013.

Note_11_Convertible_Notes_Embe

Note 11 - Convertible Notes, Embedded Conversion Feature Liability, and Gain on Extinguishment of Debt	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	11. Convertible Notes, Embedded Conversion Feature Liability, and Gain on Extinguishment of Debt
	On July 2, 2012, the Company entered into the July 2012 Private Placement for $12,000 in principal amount of senior convertible notes due on September 1, 2013 (see note 3). The notes will be convertible at any time at the option of the holders, into shares of the Company’s common stock at a conversion price of $0.352 per share. Pursuant to ASC 815-40, due to the anti-dilution provision of the convertible notes, the conversion feature of the convertible notes is not indexed to the Company’s owned stock and should be bifurcated and recognized as a derivative liability in the consolidated balance sheets and measured at fair value. The notes bear interest at 8% per annum and are payable in twelve equal monthly installments of principal and interest beginning on October 1, 2012.
	The embedded conversion feature liability and warrants issued in connection with the senior convertible notes were valued utilizing the Monte Carlo simulation and Black Sholes pricing model at $8,865 and $5,053, respectively, totaling $13,918 as of July 2, 2012. $12,000 of this total was recorded as debt discount and the excess of the face value of the embedded conversion feature liability and warrants of $1,918 were booked to debt discount amortization on July 2, 2012.
	Pursuant to the terms of the Senior Convertible Notes, the Company opted to pay the first eleven monthly installment payments due prior to June 30, 2013 with shares of the Company’s common stock, with settlement of the final installment during July 2013. Upon final settlement, the Company had issued 163,641,547 shares of common stock, at a weighted average conversion price of $0.0774, for the twelve installment payments due under the notes, consisting of $12,000 principal and $680 of interest.
	Interest expense on the convertible notes was $242 for the year ended December 31, 2013 and the Convertible Note (net of debt discount) was $0 as of December 31, 2013 as follows:
		Convertible Note			Debt Discount			Net Total
	Beginning Balance - December 31, 2012	$	7,000		$	(4,635	)	$	2,365
	Installment Payments in Shares		(7,000	)		-			(7,000	)
	Amortization		-			4,181			4,181
	Write-off associated with convertible debt extinguishment		-			454			454
	Ending Balance - December 31, 2013	$	-		$	-		$	-
	On July 17, 2013, the Company and each of the holders of the Senior Convertible Notes due on September 1, 2013, in the original aggregate principal amount of $12,000, agreed to cause all remaining principal and interest under the senior convertible notes to be converted into an aggregate of 18,679,584 shares of the Company’s common stock in full satisfaction of the notes.  As a result of this conversion, the senior convertible notes were paid off in full and are no longer outstanding as of the conversion date. As the final conversion occurred pursuant to terms that were not included in the original terms of the senior convertible notes, the Company recorded a gain on extinguishment of debt in the amount of $91 which consisted of the write-off of unamortized debt discount, unamortized debt issuance costs, embedded conversion feature liabilities, and the difference between the reacquisition price of the shares issued and the contractual conversion price of the senior convertible notes.

Note_12_Warrant_Liabilities

Note 12 - Warrant Liabilities	12 Months Ended
	Dec. 31, 2013
Warrant Liabilities [Abstract]	'
Warrant Liabilities [Text Block]	'
	12. Warrant Liabilities
	Pursuant to FASB ASC 815, the Company is required to report the value of certain warrants as a liability at fair value and record the changes in the fair value of the warrant liabilities as a gain or loss in its statement of operations and comprehensive loss due to the price-based anti-dilution rights of warrants.
	During June 2012, the Company issued warrants to purchase a total of 15,000,000 shares of common stock to Visser under the Visser MTA Agreement (see note 3). These warrants had an original exercise price of $0.22 per share and expire on June 1, 2017 and were originally valued at $4,260. The foregoing warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815. As a result of paying down our convertible notes with common stock, which resulted in an anti-dilution impact, the exercise price of these warrants was reduced to $0.21 as of December 31, 2012 and $0.18 as of December 31, 2013. In addition, the number of shares to be issued under the warrants as a result of the anti-dilution provision increased to 15,776,632 and 18,562,825 as of December 31, 2012 and December 31, 2013, respectively. As of December 31, 2013, these warrants were valued at $2,559 under the Black Sholes valuation model utilizing the following assumptions: (i) expected life of 3.42 years, (ii) volatility of 142%, (iii) risk-free interest rate of 1.75%, and (iv) dividend rate of 0. The change in warrant value for these warrants for the years ended December 31, 2013 and 2012 was a gain (loss) of $(1,299) and $3,000, respectively.
	On July 2, 2012, the Company issued warrants to purchase a total of 18,750,000 shares of common stock related to the July 2012 Private Placement (see note 3). These warrants have an exercise price of $0.384 per share and expire on July 2, 2017 and were originally valued at $5,053. The foregoing warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815. As of December 31, 2013, these warrants were valued at $2,362 under the Black Scholes valuation model utilizing the following assumptions: (i) expected life of 3.50 years, (ii) volatility of 143%, (iii) risk-free interest rate of 1.75%, and (iv) dividend rate of 0. The change in warrant value for these warrants for the years ended December 31, 2013 and 2012 was a gain (loss) of $(856) and $3,547, respectively.
	The following table summarizes the change in the Company’s warrant liability for the year ended December 31, 2013:
			Visser MTA				2-Jul-12				Total
			Agreement				Private Placement
	Beginning Balance - December 31, 2012		$	1,260			$	1,506				2,766
	Change in value of warrant liability, loss			1,299				856				2,155
	Ending Balance - December 31, 2013		$	2,559			$	2,362			$	4,921
	As of December 31, 2013 and 2012, the Company had 67,092,382 and 63,529,557 warrants outstanding. As of December 31, 2013 and 2012, the Company valued the 37,312,825 and 33,750,000 warrants using the Black-Scholes model and recorded $4,921 and $2,766, respectively, in warrant liabilities. The change in fair value of warrants resulted in a total non-cash gain (loss) of $(2,155) and $6,547 for the years ended December 31, 2013 and 2012, respectively.
	The fair value of warrants outstanding for the following periods was computed using the Black-Scholes model under the following assumptions:
			December 31,
			2013						2012
	Expected life in years			3.42	-	3.5				4.42	-	4.5
	Volatility			142%	-	143	%			151%	-	152	%
	Risk-free interest rate				1.75		%				0.72		%
	Dividend rate				0		%				0		%
	As of December 31, 2013, outstanding warrants to acquire shares of the Company’s common stock are as follows:
		Number of Shares				Exercise Price			Expiration Date
			208,334			$	0.48		15-Jul-15
			29,571,223			$	0.49		15-Jul-15
			18,562,825			$	0.178		1-Jun-17
			18,750,000			$	0.384		2-Jul-17
			67,092,382

Note_13_Shareholders_Equity_De

Note 13 - Shareholders' Equity (Deficit)	12 Months Ended
	Dec. 31, 2013
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	13. Shareholders’ Deficit
	Common stock
	In June 2012, the Company issued 30,000,000 shares of common stock to Visser in connection with the Visser MTA Agreement (see note 3).
	Pursuant to the terms of the Company’s Senior Convertible Notes issued in the July 2012 Private Placement, the Company opted to pay the twelve monthly installment payments prior to the September 1, 2013 maturity date with shares of the Company’s common stock. Upon final settlement, the Company had issued 163,641,547 shares of common stock at a weighted average conversion price of $0.0774, for the twelve installment payments due under the notes, consisting of $12,000 principal and $680 of interest (see notes 3 and 11).
	During the year ended December 31, 2013, the holders of the Company’s Series A Preferred Stock converted all of the outstanding 506,936 shares of preferred stock into 16,896,070 shares of the Company’s common stock (see “Preferred stock” below). After giving effect to such conversion, the Company has no shares of preferred stock outstanding.
	On February 28, 2013, the Company’s stockholders approved an amendment to the Certificate of Incorporation of the Company increasing the number of authorized shares of common stock from 400 million shares to 500 million shares.
	On October 24, 2013, the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation increasing the number of authorized shares of common stock from 500 million shares to 700 million shares.
	In connection with the execution of the November 8, 2013 Common Stock Purchase Agreement, the Company issued to each of the investors a pro rata portion of 2,666,667 shares of the Company’s common stock.
	Preferred stock
	On May 1, 2009, pursuant to a Securities Purchase and Exchange Agreement, the Company issued 500,000 shares of convertible Series A-1 Preferred Stock with an original issue price of $5.00 per share and 2,625,000 shares of Series A-2 Preferred Stock with an original issue price of $5.00 per share as part of a financing transaction. In October 2009, the Company entered into an agreement with various investors to issue 180,000 shares of Series A-1 Preferred Stock with identical terms as the Series A-1 Preferred Stock issued on May 1, 2009. In connection with this issuance, the Company issued warrants to purchase up to 4,500,000 shares of common stock with an exercise price of $0.50 per share, which was subsequently adjusted to $0.49 per share due to an anti-dilution calculation. These warrants expired on January 3, 2012.
	The Series A Preferred Stock and any accrued and unpaid dividends thereon was convertible, at the option of the holders of the Series A Preferred Stock, into common stock of the Company at a conversion price of $0.10 per share in the case of the Series A-1 Preferred Stock and a conversion price of $0.22 per share in the case of the Series A-2 Preferred Stock (in both cases subject to adjustments for any stock dividends, splits, combinations and similar events).
	In connection with the Series A Preferred Stock issuance, the Company issued warrants to purchase 42,329,407 shares of the Company’s common stock at an exercise price of $0.50 per share, which was subsequently adjusted to $0.49 per share due to an anti-dilution calculation. The warrants also expired on January 3, 2012.
	During the year ended December 31, 2012, the holders of the Company’s Series A Preferred Stock converted 792,215 shares of preferred stock into 25,669,752 shares of the Company’s common stock. As of December 31, 2012, the Company had 506,936 shares of Series A Preferred Stock outstanding, consisting of 105,231 and 401,705 shares of Series A-1 and Series A-2 Preferred Stock, respectively. Preferred stock as of December 31, 2012 was $0 due to an insignificant balance, and accrued dividends on the Series A Preferred Stock as of December 31, 2012 were $222.
	During the year ended December 31, 2013, all of the holders of the Company’s Series A Preferred Stock converted all of the outstanding shares of preferred stock and accrued dividends into 16,896,070 shares of the Company’s common stock. Therefore, as of December 31, 2013, the Company no longer had any outstanding Preferred Stock and the related $222 accrued dividends were reclassified to additional paid-in capital as of December 31, 2013.
	Warrants
	In connection with the Series A Preferred Stock issuances, warrants to purchase 29,779,557 shares of the Company’s common stock were outstanding as of December 31, 2012 and December 31, 2013. These warrants do not contain anti-dilution provisions and are reflected as equity as they do not meet the criteria under FASB ASC 815 for liability treatment. Warrants classified as equity were recorded at $18,179 as of December 31, 2012 and December 31, 2013. Such warrants have an exercise price ranging between $0.48 and $0.49 and expire on July 15, 2015.

Note_14_Stock_Compensation_Pla

Note 14 - Stock Compensation Plan	12 Months Ended
	Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	'
	14. Stock Compensation Plan
	On April 4, 2002, our shareholders and Board of Directors adopted the 2002 Equity Incentive Plan (“2002 Plan”). The 2002 Plan provides for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. A total of 10,000,000 shares of our common stock may be granted under the 2002 Plan. The 2002 Plan expired by its terms in April 2012, but it will remain in effect only with respect to the equity awards that have been granted prior to its expiration. As of December 31, 2013, there were 2,607,000 options outstanding under the 2002 Plan.
	On June 28, 2012, the Company adopted the 2012 Equity Incentive Plan (“2012 Plan”), with the approval of the shareholders, which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. The 2012 Plan provides for the granting to employees of incentive stock options within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended, and for the granting to employees and consultants of non-statutory stock options. In addition, the Plan permits the granting of stock appreciation rights, or SARs, with or independently of options, as well as stock bonuses and rights to purchase restricted stock. A total of thirty million shares of our common stock may be granted under the 2012 Equity Incentive Plan, and all options granted under this plan had exercise prices that were equal to the fair market value on the date of grant. During 2013, the Company granted options to purchase 13,317,500 shares, with total options outstanding of 13,127,500 as of December 31, 2013.
	FASB ASC 718, Compensation – Stock Compensation, requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under ASC 718, Company is required to measure the cost of employee services received in exchange for stock options and similar awards based on the grant-date fair value of the award and recognize this cost in the income statement over the period during which an employee is required to provide service in exchange for the award. The Company recorded $525 and $363 for the years ended December 31, 2013 and 2012, respectively, of non-cash charges for stock compensation related to amortization of the fair value of restricted stock and unvested stock options. The total compensation costs related to non-vested awards not yet recognized were $487 and $113 for the years ended December 31, 2013 and 2012, respectively.
	On August 3, 2010, in conjunction with an employment agreement with Thomas Steipp, the Company’s Chief Executive Officer, the Company also granted an aggregate of 6,000,000 restricted shares of the Company’s common stock, which will ratably vest each year over five years. During the years December 31, 2013 and 2012, the Company recorded $312 and $310, respectively, of compensation expense related to Mr. Steipp’s restricted shares.
	The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the assumptions noted in the following table.
			December 31,
			2013						2012
	Expected volatility			128.55%	-	168.09%				140.74%	-	143.23%
	Expected dividends				-						-
	Expected term (in years)			6.32	-	9.61					6.5
	Risk-free rate			1.26%	-	2.49%				0.98%		1.04%
	Expected volatilities are based on historical volatility expected over the expected life of the options. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. A forfeiture rate of 28.3% was used for options grated during both years ended December 31, 2013 and 2012. The risk free rate for period within the expected life of the options is based on U.S. Treasury rates in effect at the time of grant.
	The following table summarizes the Company’s stock option transactions for the years ended December 31, 2013 and 2012:
			Number of				Weighted Average				Weighted				Aggregate Intrinsic Value
			Shares				Exercise Price				Average
											Remaining
											Contractual
											Term
															(in thousands)
	Options outstanding at December 31, 2011			4,679,807				0.42
	Granted			330,000				0.28
	Exercised			(354,000	)			0.12
	Forfeited			(396,200	)			0.31
	Expired			(537,607	)			1
	Options outstanding at December 31, 2012			3,722,000				0.36
	Granted			13,317,500				0.08
	Exercised			(600,000	)			0.12
	Forfeited			(605,000	)			0.2
	Expired			(100,000	)			2.49
	Options outstanding at December 31, 2013			15,734,500			$	0.13				8.4			$	1,155
	Options exercisable at December 31, 2013			1,677,000			$	0.45				3.6			$	38
	Options unvested at December 31, 2013			14,057,500			$	0.09				8.9			$	1,117
	Options vested or expected to vest at December 31, 2013			10,174,928			$	0.15				8			$	714
	The following table summarizes the Company’s stock options outstanding and exercisable by ranges of option prices as of December 31, 2013:
	Options Outstanding																Options Exercisable
	Range of				Numbers of				Weighted				Weighted				Number of		Weighted		Weighted
	Exercise Prices				options				Average				Average				Options		Average		Average
					Outstanding				Remaining Contractual				Exercise Price				Exercisable		Remaining Contractual		Exercise Price
									Life (Years)										Life (Years)
	$0.00	-	0.1			12,717,500				9.04			$	0.08				200,000		4.92	$	0.09
	0.11	-	2.33			3,017,000				5.6				0.32				1,477,000		3.44		0.5
		Total				15,734,500												1,677,000
	The Company’s non-vested options at the beginning and ending of fiscal year 2013 had weighted-average grant-date fair values of $0.11 and $0.08 per option, respectively.

Note_15_Income_Taxes

Note 15 - Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	15. Income Taxes
	Significant components of deferred tax assets are as follows:
		Years Ended December 31,
		2013			2012
	Loss carry forwards	$	50,165		$	60,426
	Debt Discount		891			(1,523	)
	NQSO		628			422
	Tax Credits		431			432
	Other		259			120
	Total deferred tax asset		52,374			59,877
	Valuation allowance		(52,374	)		(59,877	)
	Total deferred tax asset, net		-			-
	The following table accounts for the differences between the expected federal tax benefit (based on the statutory U.S. federal income tax rate of 34%) and the actual tax provision:
		Years Ended December 31,
		2013			2012
	Expected federal tax benefit		-34	%		-34	%
	Permanent items		0.1	%		0.1	%
	Net operating loss utilized or expired		0	%		5.5	%
	Increase in valuation allowance and others		33.9	%		28.4	%
	Total deferred tax asset		0	%		0	%
	As of December 31, 2013, the Company had approximately $126.6M of net operating loss (“NOL”) carryforwards for U.S. federal income tax and state tax purposes expiring in 2018 through 2033, and 2014 through 2033, respectively. The Company and Liquidmetal Golf, Inc. filed on a separate company basis for federal income tax purposes. Accordingly, the federal NOL carryforwards of one legal entity are not available to offset federal taxable income of the other. Liquidmetal Golf, Inc. had approximately $35.9 in federal NOL carryforwards, expiring in 2018 through 2028.
	As of December 31, 2013, the Company had approximately $189 of Research & Development (“R&D”) credit carryforwards for U.S. federal income tax purposes expiring in 2021 through 2030. In addition, the Company has California R&D credit carryforwards of approximately $243, which do not expire under current California law.
	Section 382 of the Internal Revenue Code (“IRC”) imposes limitations on the use of NOL’s and credits following changes in ownership as defined in the IRC. The limitation could reduce the amount of benefits that would be available to offset future taxable income each year, starting with the year of an ownership change. The Company has not completed the complex analysis required by the IRC to determine if an ownership change has occurred.
	The ability to realize the tax benefits associated with deferred tax assets, which includes benefits related to NOL’s, is principally dependent upon the Company’s ability to generate future taxable income from operations. The Company has provided a full valuation allowance for its net deferred tax assets due to the Company’s net operating losses.
	The Company adopted the provisions of FASB ASC Topic 470 – Income Taxes. At the adoption date and as of December 31, 2013, the Company had no material unrecognized tax benefits and no adjustments to liabilities or operations were required. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense which were $0 for the year ended December 31, 2013 and 2012.
	As of December 31, 2013, the tax years 2011 through 2012, and 2008 through 2012 are subject to examination by the federal and California taxing authorities, respectively.

Note_16_Loss_Per_Common_Share

Note 16 - Loss Per Common Share	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	16. Loss Per Common Share
	Basic earnings per share (“EPS”) is computed by dividing earnings (loss) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution of securities that could share in the earnings.
	Options to purchase 15,734,500 shares of common stock at prices ranging from $0.08 to $2.33 per share were outstanding at December 31, 2013, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Options to purchase 3,722,000 shares of common stock at prices ranging from $0.09 to $5.00 per share were outstanding at December 31, 2012, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss.
	Warrants to purchase 67,092,382 shares of common stock, with prices ranging from $0.18 to $0.49 per share, outstanding at December 31, 2013 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 63,529,557 shares of common stock, with prices ranging from $0.22 to $0.49 per share, outstanding at December 31, 2012 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss.
	16,896,073 shares of common stock issuable upon conversion of the company’s preferred stocks with conversion process between $0.10 and $0.22 per share outstanding at December 31, 2012 were not included in the computation of diluted EPS for the period as the inclusion would have been antidilutive, given the Company’s net loss. No shares of preferred stock were outstanding as of December 31, 2013.

Note_17_Commitments_and_Contin

Note 17 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	17. Commitments and Contingencies
	Operating Lease Commitments
	The Company leases its offices and warehouse facilities under various lease agreements, certain of which are subject to escalations based upon increases in specified operating expenses or increases in the Consumer Price Index. As of December 31, 2013 and 2012, the Company has recorded $39 and $28, respectively, of deferred rent expenses. Future minimum lease payments under non-cancelable operating leases during subsequent years are as follows:
	December 31,	Minimum Payments
	2014		210
	2015		217
	2016		73
	Total		500
	Rent expense was $200 and $214 for the years ended December 31, 2013 and 2012, respectively.
	Contingencies
	In November 2013, Visser and the Company entered into arbitration proceedings with the Judicial Arbiter Group in Denver, CO. Both parties have filed claims alleging breaches of various obligations under the Visser MTA Agreement entered into on June 1, 2012.
	In general, the Company has filed claims for damages against Visser for fraudulently inducing them into entering the Visser MTA Agreement and harm inflicted on them for Visser’s failure to perform under the manufacturing component of the Visser MTA Agreement. In addition, the Company is seeking reformation and/or termination of parts of the Visser MTA Agreement in order to free them from the exclusive manufacturing arrangement with Visser and allow them to seek other manufacturing partners. Visser has also filed claims for damages against the Company alleging several violations of the Visser MTA Agreement including fraudulent contract inducement and securities fraud through alleged misrepresentations regarding the Company’s future capitalization, breach of several components of the Visser MTA Agreement through alleged inappropriate sharing of intellectual property with other business partners, as well as the lack of a qualified sales force in marketing of the Company’s technology and related production efforts of Visser. Visser also requests equitable relief in the form of orders increasing its stock ownership and requiring the Company to honor its asserted rights of first refusal with respect to Liquidmetal technology. The Company cannot predict the outcome of these matters or estimate the impact on its results of operations, financial position or cash flows. As a result, the Company has not recorded a liability for these matters. If the Company is unable to reach a settlement agreement with Visser, the arbitration hearing is expected to commence on June 16, 2014, and will last up to ten days.

Note_18_401k_Savings_Plan

Note 18 - 401(k) Savings Plan	12 Months Ended
	Dec. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'
Pension and Other Postretirement Benefits Disclosure [Text Block]	'
	18. 401(k) Savings Plan
	The Company has a tax-qualified employee savings and retirement plan, or 401(k) plan. Under the 401 (k) plan, participants may elect to reduce their current compensation, on a pre-tax basis, by up to 15% of their taxable compensation or of the statutorily prescribed annual limit, whichever is lower, and have the amount of the reduction contributed to the 401(k) plan. The 401(k) plan permits the Company, in its sole discretion, to make additional employer contributions to the 401(k) plan. However, the Company did not make employer contributions to the 401(k) plan during any of the periods presented in the accompanying consolidated financial statements.

Note_19_Related_Party_Transact

Note 19 - Related Party Transactions	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	19. Related Party Transactions
	On October 14, 2010, the Company signed an agreement with Innovative Materials Group, LLC (“IMG”), a California limited liability company, which is majority owned by Mr. Kang. Under the agreement, the Company received a deposit of $520 from IMG to purchase on behalf of IMG, machinery and equipment located in China. The transaction was based on the potential negotiation and completion of a non-exclusive license agreement with IMG under which the machinery and equipment would be transferred to IMG either directly or through the transfer of ownership of the Company’s Chinese subsidiary, Advanced Metals Materials (“AMM”), that owns the equipment.
	On August 5, 2011, the Company signed a Stock Purchase Agreement (the “Stock Purchase Agreement”) with IMG to sell all of the stock of AMM for $720 (the “Purchase Price”). IMG applied the payment of the Purchase Price the $520 deposit previously paid to the Company and the $200 balance of the Purchase Price was paid in the form of a Promissory Note due August 5, 2012, bearing an interest rate of 8% per annum. In conjunction with the Stock Purchase Agreement, the Company also entered into a License Agreement (the “IMG License Agreement”) with IMG to license certain patents and technical information for the limited purpose of manufacturing certain licensed products with the Company’s existing first generation, die cast machines, as defined by the IMG License Agreement (the “Licensed Products”). The IMG License Agreement grants a non-exclusive license to certain product categories, as well as an exclusive license to specific types of consumer eyewear products and obligates IMG to pay the Company a running royalty based on its sales of Licensed Products. The license will expire on August 5, 2021. The Company recognized $8 and $26 in royalty revenues from IMG during the years ended December 31, 2013 and 2012, respectively.
	On December 31, 2012, IMG and the Company signed an amendment to the IMG License Agreement whereby the $200 Promissory Note from IMG along with the accrued interest of $21 was forgiven in exchange for the return of the eyewear license to the Company. The Company accounted for this transaction as an exchange of non-monetary assets and re-classed the $221 thousand to eyewear license fee. While the company continues to maintain an active interest in leveraging the eyewear license for prospective opportunities in the eyewear industry from both a products and licensing perspective, the Company determined that there was insufficient historical market data on the potential license applications presently available to provide a reasonable basis to fair value the license and its period of useful life. Therefore, the Company recognized a $221 thousand impairment loss for accounting purposes as of December 31, 2012.
	During the years ended December 31, 2013 and 2012, the Company incurred $0 and $2 in legal fees, respectively, to defend Mr. Kang, as the former Representative Director of our Korean subsidiary, against allegations relating to the Company’s Korean subsidiary’s involvement in customs reporting violations in South Korea that allegedly occurred in 2007 and 2008. The Company had agreed to reimburse Mr. Kang’s legal fees incurred on this issue through December 31, 2012.
	On February 1, 2012, Mr. Tony Chung, the Company’s Chief Financial Officer, converted his 10,000 shares of Series A-1 Preferred Stock into a total of 565,344 shares of the Company’s common stock, including dividends received in the form of common stock. On June 13, 2013, Mr. Chung purchased 1,324,999 shares of Company’s common stock at an average share price of $0.078.
	In February 2013, Mr. Abdi Mahamedi, the Company’s Chairman, converted his 58,600 shares of Series A-1 Preferred Stock and 260,710 shares of Series A-2 Preferred Stock into a total of 10,387,883 shares of the Company’s common stock, including dividends received in the form of common stock. Mr. Mahamedi is a greater-than-5% beneficial owner of the Company.
	Mr. Thomas Steipp, the Company’s Chief Executive Officer, sold an aggregate of 400,000 shares of the common stock of the Company on August 5, 2013 pursuant to a trading plan that Mr. Steipp previously adopted under SEC Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Mr. Steipp adopted the trading plan on March 22, 2013 for the purpose of providing him with funds to satisfy certain tax liabilities as a result of the vesting on August 3, 2013 of 1,200,000 shares of Company restricted common stock held by Mr. Steipp. The restricted shares were granted to Mr. Steipp in 2010 under a previously disclosed Restricted Stock Award Agreement, dated August 3, 2010, between Mr. Steipp and the Company. The trading plan also provides for the future sale of 400,000 shares of Company common stock scheduled for August 4, 2014.
	In September 2013, the Company entered into Change of Control Agreements with Ricardo A. Salas, the Company’s Executive Vice President, Tony Chung, the Company’s Chief Financial Officer, and certain other executive officers who are not named executive officers of the Company for SEC reporting purposes. The Change of Control Agreements provide that if the executive officer’s employment with the Company is terminated without cause during the one-year period after a change of control of the Company, then the terminated officer will receive lump sum severance compensation in an amount equal to twelve months of his then-current base salary. Under the agreements, each of the executive officers will also be entitled to the above-described severance compensation in the event he terminates his own employment within one year after a change of control because of a salary decrease or assignment to a lower-level position. In addition, upon termination, all unvested stock options related to these officers will automatically and immediately vest and shall thereafter be exercisable in accordance with the terms and provisions of the applicable award agreements.
	The Company has an exclusive license agreement with LLPG, Inc. (“LLPG”), a corporation owned principally by Jack Chitayat, a former director of the Company. Under the terms of the agreement, LLPG has the right to commercialize Liquidmetal alloys, particularly precious-metal based compositions, in jewelry and high-end luxury product markets. The Company, in turn, will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by LLPG. The exclusive license agreement with LLPG expires on December 31, 2021. There were no revenues recognized from product sales and licensing fees from LLPG during 2013 and 2012.
	On February 27, 2013, Mr. Chitayat converted his 28,928 shares of Series A-1 Preferred Stock and 109,528 shares of Series A-2 Preferred Stock into a total of 4,626,840 shares of the Company’s common stock, including dividends received in the form of common stock.
	On June 1, 2012, the Company entered into a Master Transaction Agreement with Visser Precision Cast, LLC relating to a strategic transaction for manufacturing services and financing (see note 3). In November 2013, the Company and Visser entered into arbitration proceedings to resolve disputes associated with this agreement. As of December 31, 2013, Visser is a greater-than-5% beneficial owner of the Company.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Consolidation, Policy [Policy Text Block]	'
	Principles of Consolidation. The consolidated financial statements include the accounts of Liquidmetal Technologies, Inc. and its special-purpose wholly-owned subsidiaries, Crucible Intellectual Property and Liquidmetal Golf. All intercompany balances and transactions have been eliminated.
Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]	'
	Non-controlling interest. The results of operations attributable to the non-controlling interest of subsidiaries are presented within equity and are shown separately from the Company’s equity.
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition. Revenue is recognized pursuant to applicable accounting standards including FASB ASC Topic 605 (“ASC 605”), Revenue Recognition. ASC 605 summarize certain points of the SEC staff’s views in applying generally accepted accounting principles to revenue recognition in financial statements and provide guidance on revenue recognition issues in the absence of authoritative literature addressing a specific arrangement or a specific industry.
	The Company’s revenue recognition policy complies with the requirements of ASC 605. Revenue is recognized when i) persuasive evidence of an arrangement exists, ii) delivery has occurred, iii) the sales price is fixed or determinable, iv) collection is probable and v) all obligations have been substantially performed pursuant to the terms of the arrangement. Revenues primarily consist of the sales and prototyping of Liquidmetal molds and bulk alloys, licensing and royalties for the use of the Liquidmetal brand and bulk Liquidmetal alloys. Revenue is deferred and included in liabilities when the Company receives cash in advance for goods not yet delivered or if the licensing term has not begun.
	License revenue arrangements in general provide for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include the grant of an exclusive or non-exclusive right to manufacture and/or sell products covered by patented technologies owned or controlled by the Company. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time.
	Licensing revenues that are one time fees upon the granting of the license are recognized when i) the license term begins in a manner consistent with the nature of the transaction and the earnings process, ii) when collectability is reasonably assured or upon receipt of an upfront fee, and iii) when all other revenue recognition criteria have been met. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the license. Licensing revenues that are related to royalties are recognized as the royalties are earned over the related period.
Cash and Cash Equivalents, Policy [Policy Text Block]	'
	Cash. The Company considers all highly liquid investments with maturity dates of three months or less when purchased to be cash equivalents. The Company limits the amount of credit exposure to each individual financial institution and places its temporary cash into investments of high credit quality with a financial institution that exceeds federally insured limits. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal. As of December 31, 2013 and 2012, the Company held no deposits in such highly liquid investments.
Receivables, Policy [Policy Text Block]	'
	Trade Accounts Receivable. The Company grants credit to its customers generally in the form of short-term trade accounts receivable. The creditworthiness of customers is evaluated prior to signing a contract with the customer. As of December 31, 2013, three customers represented 99%, or $212, of the total outstanding trade accounts receivable. As of December 31, 2012, three customers represented 96%, or $72, of the total outstanding trade accounts receivable. During 2013, there was one major customer, who accounted for 80% of the revenue. During 2012, there were three major customers, who together accounted for 70% of the revenue. In the future, the Company expects that a significant portion of the revenue may continue to be concentrated in a limited number of customers, even if the bulk alloys business grows.
	The allowance for doubtful accounts reflects management's best estimate of probable losses inherent in the trade accounts receivable.  Management primarily determines the allowance based on the aging of accounts receivable balances, historical write-off experience, customer concentrations, customer creditworthiness and current industry and economic trends.  The Company's provisions for uncollectible receivables are included in selling, marketing, general and administrative expense in the accompanying consolidated statements of operations and comprehensive loss.
Property, Plant and Equipment, Policy [Policy Text Block]	'
	Property and Equipment. Property and equipment are stated at cost less accumulated depreciation and amortization. Additions and major renewals are capitalized. Repairs and maintenance are charged to expense as incurred. Upon disposal, the related cost and accumulated depreciation are removed from the accounts, with the resulting gain or loss included in operating income. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets, which range from one to five years.
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]	'
	Intangible Assets. Intangible assets consist of the costs incurred to purchase patent rights and costs incurred to internally develop patents and trademarks. Intangible assets are reported net of accumulated amortization. Patents and trademarks are amortized using the straight-line method over a period based on their contractual lives ranging from ten to seventeen years.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	'
	Impairment of Long-lived Assets. The Company reviews long-lived assets to be held and used in operations for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may be impaired. An impairment loss is recognized when the estimated fair value of the assets is less than the carrying value of the assets.
Fair Value Measurement, Policy [Policy Text Block]	'
	Fair Value Measurements. The estimated fair values of amounts reported in the consolidated financial statements have been determined using available market information and valuation methodologies, as applicable. The fair value of cash and trade receivables, prepaid expenses and other current assets, accounts payable, and accrued liabilities approximate their carrying value due to their short maturities. The fair value of non-current assets and liabilities approximate their carrying value unless otherwise stated. The carry amounts reported for debt obligations approximate fair value due to the effective interest rate of these obligations reflecting the Company’s current borrowing rate.
	Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value based upon the following fair value hierarchy:
	Level 1 —	Quoted prices in active markets for identical assets or liabilities;
	Level 2 —	Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
	Level 3 —	Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	The Company has one Level 2 financial instrument, warrants that are recorded at fair value on a periodic basis. Warrants are evaluated under the hierarchy of FASB ASC Subtopic 480-10, FASB ASC Paragraph 815-25-1 and FASB ASC Subparagraph 815-10-15-74 addressing embedded derivatives. The fair value of such warrants is estimated using the Black-Scholes option pricing model. The foregoing warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815 (see note 12).
	The Company had one Level 3 financial instrument during the year ended December 31, 2013, that being an embedded derivative that was recorded at fair value on a periodic basis. The embedded derivative was evaluated under the hierarchy of FASB ASC Subtopic 480-10, FASB ASC Paragraph 815-25-1 and FASB ASC Subparagraph 815-10-15-74 addressing embedded derivatives. The fair value of such embedded derivative was estimated using the Monte Carlo simulation model. The foregoing embedded derivative had certain anti-dilution and exercise price reset provisions which qualified the embedded derivative to be classified as a liability under FASB ASC 815. Upon the final settlement of the Senior Convertible Notes, this liability was extinguished as the underlying conversion option had been executed. As such, the fair value of the liability was reduced to zero upon conversion (see note 11).
	As of December 31, 2013, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:
			Fair Value		Level 1		Level 2		Level 3
	Warrant liabilities			-		-		4,921		-
Research and Development Expense, Policy [Policy Text Block]	'
	Research and Development Expenses. Research and development expenses represent salaries, related benefits expense, expenses incurred for the design and testing of new processing methods and other expenses related to the research and development of Liquidmetal alloys. Development costs incurred in research and development activities are expensed as incurred.
Advertising Costs, Policy [Policy Text Block]	'
	Advertising and Promotion Expenses. Advertising and promotion expenses are expensed when incurred. Advertising and promotion expenses were $78 and $41, for the years ended December 31, 2013 and 2012, respectively.
Legal Costs, Policy [Policy Text Block]	'
	Legal Costs. Legal costs are expensed as incurred.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	Stock-Based Compensation. The Company accounts for share-based compensation in accordance with the fair value recognition provisions of FASB ASC Topic 718, Share-based Payment, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated financial statements based on their fair values. The fair value of stock options is calculated by using the Black-Scholes option pricing formula that requires estimates for expected volatility, expected dividends, the risk-free interest rate and the term of the option. If any of the assumptions used in the Black-Scholes model change significantly, share-based compensation expense may differ materially in the future from that recorded in the current period.
Income Tax, Policy [Policy Text Block]	'
	Income Taxes. Income taxes are provided under the asset and liability method as required by FASB ASC Topic 740, Accounting for Income Taxes. Under this method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax basis of existing assets and liabilities. The effect of a tax rate change on deferred taxes is recognized in operations in the period that the change in the rate is enacted. Valuation allowances are established when necessary to reduce net deferred tax assets to the amount expected to be realized. Under the provision of FASB ASC Topic 740, the Company had no material unrecognized tax benefits and no adjustments to liabilities or operations were required. The Company may recognize interest and penalties related to uncertain tax positions in income tax expense. There was no expense related to interest and penalties for the year ended December 31, 2013 and 2012.
Earnings Per Share, Policy [Policy Text Block]	'
	Earnings Per Share. Basic earnings per share (“EPS”) is computed by dividing earnings (losses) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates. These management estimates are primarily related to impairment of long-lived assets, allowance for bad debt account balances, and warrant valuation.
Subsequent Events, Policy [Policy Text Block]	'
	Subsequent Events. In May 2009, the FASB issued a new accounting standard which established general accounting standards and disclosure for subsequent events. In accordance with this standard, the Company evaluated subsequent events through the filing of its Annual Report on Form 10-K with the SEC.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recent Accounting Pronouncements.
	Offsetting Assets and Liabilities
	In December 2011 and December 2012, the FASB issued accounting standards updates modifying the disclosure requirements about the nature of an entity's rights of offsetting assets and liabilities in the consolidated balance sheet under master netting agreements and related arrangements associated with financial and derivative instruments. The guidance requires increased disclosure of the gross and net recognized assets and liabilities, collateral positions and narrative descriptions of setoff rights. The adoption of this pronouncement did not have a material impact on the Company’s Consolidated Financial Statements and accompanying disclosures.
	Presentation of Items Reclassified out of Accumulated Other Comprehensive Income
	In February 2013, the FASB issued an accounting standards update which requires disclosure related to items reclassified out of accumulated other comprehensive income (AOCI). The guidance requires entities to present separately, for each component of other comprehensive income (OCI), current period reclassifications and the remainder of the current-period OCI. In addition, for certain current period reclassifications, an entity is required to disclose the effect of the item reclassified out of AOCI on the respective line item of net income. The adoption of this pronouncement did not have a material impact on the Company’s Consolidated Financial Statements and accompanying disclosures.
	Joint and Several Liabilities
	In February 2013, the FASB issued an accounting standard update which modifies the requirements for the recognition, measurement, and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation is fixed at the reporting date. The guidance requires companies to measure these obligations as the sum of the amount the company has agreed with co-obligors to pay and any additional amount it expects to pay on behalf of one or more co-obligors. This guidance is effective for all fiscal years, and interim periods within those years, beginning after December 31, 2013. The Company does not expect this guidance to have a material impact on the Company’s Consolidated Financial Statements.
	Presentation of Unrecognized Tax Benefits
	In July 2013, the FASB issued an accounting standards update which will require that an unrecognized tax benefit be presented on the balance sheet as a reduction of a deferred tax asset for a net operating loss ("NOL") or tax credit carryforward under certain circumstances. The guidance is effective for all fiscal years, and interim periods within those years, beginning December 15, 2013.  The Company does not expect this guidance to have a material impact on the Company’s Consolidated Financial Statements.

Note_2_Summary_of_Significant_1

Note 2 - Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'
		Fair Value		Level 1		Level 2		Level 3
	Warrant liabilities		-		-		4,921		-

Note_5_Trade_accounts_receivab1

Note 5 - Trade accounts receivable (Tables)	12 Months Ended
	Dec. 31, 2013
Receivables [Abstract]	'
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	'
		December 31,
		2013		2012
	Trade accounts receivable	$	215	$	75
	Less: Allowance for doubtful accounts		-		(11	)
	Trade accounts receivable, net	$	215	$	64

Note_7_Property_and_Equipment_

Note 7 - Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
		December 31,
		2013			2012
	Machinery and equipment	$	1,107		$	1,098
	Computer equipment		203			118
	Office equipment, furnishings, and improvements		277			190
	Total		1,587			1,406
	Accumulated depreciation		(1,338	)		(1,245	)
	Total property and equipment, net	$	249		$	161

Note_8_Patents_and_Trademarks_1

Note 8 - Patents and Trademarks, net (Tables)	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block [Abstract]	'
Schedule of Finite-Lived Intangible Assets [Table Text Block]	'
		December 31,
		2013			2012
	Purchased and licensed patent rights	$	566		$	566
	Internally developed patents		1,664			1,664
	Trademarks		139			126
	Total		2,369			2,356
	Accumulated amortization	$	(1,605	)	$	(1,487	)
	Total intangible assets, net	$	764		$	869
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	'
	December 31,	Aggregate Amortization Expense
	2014		103
	2015		97
	2016		95
	2017		84
	2018		83
	Thereafter		302
Finite-Lived Intangible Assets Accumulated Amortization Table Text Block	'
		December 31,
		2013			2012
	Purchased and licensed patent rights	$	(483	)	$	(457	)
	Internally developed patents		(1,022	)		(937	)
	Trademarks		(100	)		(93	)
	Total	$	(1,605	)	$	(1,487	)
Finite-Lived Intangible Assets Weighted Average Amortization Periods Table Text Block	'
		December 31,
		2013			2012
	Purchased and licensed patent rights		17			17
	Internally developed patents		17			17
	Trademarks		10			10

Note_11_Convertible_Notes_Embe1

Note 11 - Convertible Notes, Embedded Conversion Feature Liability, and Gain on Extinguishment of Debt (Tables)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Schedule of Debt [Table Text Block]	'
		Convertible Note			Debt Discount			Net Total
	Beginning Balance - December 31, 2012	$	7,000		$	(4,635	)	$	2,365
	Installment Payments in Shares		(7,000	)		-			(7,000	)
	Amortization		-			4,181			4,181
	Write-off associated with convertible debt extinguishment		-			454			454
	Ending Balance - December 31, 2013	$	-		$	-		$	-

Note_12_Warrant_Liabilities_Ta

Note 12 - Warrant Liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Note 12 - Warrant Liabilities (Tables) [Line Items]	'
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	'
			Visser MTA				2-Jul-12				Total
			Agreement				Private Placement
	Beginning Balance - December 31, 2012		$	1,260			$	1,506				2,766
	Change in value of warrant liability, loss			1,299				856				2,155
	Ending Balance - December 31, 2013		$	2,559			$	2,362			$	4,921
Fair Value Assumptions Used For Warrants Outstanding Table Text Block	'
			December 31,
			2013						2012
	Expected life in years			3.42	-	3.5				4.42	-	4.5
	Volatility			142%	-	143	%			151%	-	152	%
	Risk-free interest rate				1.75		%				0.72		%
	Dividend rate				0		%				0		%
Warrants Outstanding [Member]	'
Note 12 - Warrant Liabilities (Tables) [Line Items]	'
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	'
		Number of Shares				Exercise Price			Expiration Date
			208,334			$	0.48		15-Jul-15
			29,571,223			$	0.49		15-Jul-15
			18,562,825			$	0.178		1-Jun-17
			18,750,000			$	0.384		2-Jul-17
			67,092,382

Note_14_Stock_Compensation_Pla1

Note 14 - Stock Compensation Plan (Tables)	12 Months Ended
	Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'
			December 31,
			2013						2012
	Expected volatility			128.55%	-	168.09%				140.74%	-	143.23%
	Expected dividends				-						-
	Expected term (in years)			6.32	-	9.61					6.5
	Risk-free rate			1.26%	-	2.49%				0.98%		1.04%
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
			Number of				Weighted Average				Weighted				Aggregate Intrinsic Value
			Shares				Exercise Price				Average
											Remaining
											Contractual
											Term
															(in thousands)
	Options outstanding at December 31, 2011			4,679,807				0.42
	Granted			330,000				0.28
	Exercised			(354,000	)			0.12
	Forfeited			(396,200	)			0.31
	Expired			(537,607	)			1
	Options outstanding at December 31, 2012			3,722,000				0.36
	Granted			13,317,500				0.08
	Exercised			(600,000	)			0.12
	Forfeited			(605,000	)			0.2
	Expired			(100,000	)			2.49
	Options outstanding at December 31, 2013			15,734,500			$	0.13				8.4			$	1,155
	Options exercisable at December 31, 2013			1,677,000			$	0.45				3.6			$	38
	Options unvested at December 31, 2013			14,057,500			$	0.09				8.9			$	1,117
	Options vested or expected to vest at December 31, 2013			10,174,928			$	0.15				8			$	714
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	'
	Options Outstanding																Options Exercisable
	Range of				Numbers of				Weighted				Weighted				Number of		Weighted		Weighted
	Exercise Prices				options				Average				Average				Options		Average		Average
					Outstanding				Remaining Contractual				Exercise Price				Exercisable		Remaining Contractual		Exercise Price
									Life (Years)										Life (Years)
	$0.00	-	0.1			12,717,500				9.04			$	0.08				200,000		4.92	$	0.09
	0.11	-	2.33			3,017,000				5.6				0.32				1,477,000		3.44		0.5
		Total				15,734,500												1,677,000

Note_15_Income_Taxes_Tables

Note 15 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
		Years Ended December 31,
		2013			2012
	Loss carry forwards	$	50,165		$	60,426
	Debt Discount		891			(1,523	)
	NQSO		628			422
	Tax Credits		431			432
	Other		259			120
	Total deferred tax asset		52,374			59,877
	Valuation allowance		(52,374	)		(59,877	)
	Total deferred tax asset, net		-			-
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'
		Years Ended December 31,
		2013			2012
	Expected federal tax benefit		-34	%		-34	%
	Permanent items		0.1	%		0.1	%
	Net operating loss utilized or expired		0	%		5.5	%
	Increase in valuation allowance and others		33.9	%		28.4	%
	Total deferred tax asset		0	%		0	%

Note_17_Commitments_and_Contin1

Note 17 - Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	'
	December 31,	Minimum Payments
	2014		210
	2015		217
	2016		73
	Total		500

Note_1_Description_of_Business1

Note 1 - Description of Business (Details)	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block [Abstract]	'
Percentages of stronger than zirconium titanium Liquidmetal alloys	250.00%

Note_2_Summary_of_Significant_2

Note 2 - Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Accounts Receivable, Gross, Current (in Dollars)	$215,000	$75,000
Embedded Derivative, Fair Value of Embedded Derivative Liability (in Dollars)	0	'
Advertising Expense (in Dollars)	78,000	41,000
Trade Accounts Receivable [Member]	'	'
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Concentration Risk, Percentage	99.00%	96.00%
Accounts Receivable, Gross, Current (in Dollars)	$212,000	$72,000
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member]	'	'
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Concentration Risk Number of Major Customers	3	3
Concentration Risk, Percentage	80.00%	70.00%
Minimum [Member]	'	'
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Property, Plant and Equipment, Useful Life	'1 year	'
Finite-Lived Intangible Asset, Useful Life	'10 years	'
Maximum [Member]	'	'
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Property, Plant and Equipment, Useful Life	'5 years	'
Finite-Lived Intangible Asset, Useful Life	'17 years	'

Note_2_Summary_of_Significant_3

Note 2 - Summary of Significant Accounting Policies (Details) - Fair Value of Items Measured on a Recurring Basis (Fair Value, Measurements, Recurring [Member], Fair Value, Inputs, Level 2 [Member], USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]	'
Note 2 - Summary of Significant Accounting Policies (Details) - Fair Value of Items Measured on a Recurring Basis [Line Items]	'
Warrant liabilities	$4,921

Note_3_Significant_Transaction1

Note 3 - Significant Transactions (Details) (USD $)

12 Months Ended

1 Months Ended

0 Months Ended

7 Months Ended

3 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Nov. 08, 2013

Oct. 31, 2009

2-May-09

Nov. 08, 2013

Jul. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Jul. 02, 2012

Jul. 31, 2013

Dec. 31, 2012

Jun. 30, 2012

Dec. 31, 2012

Jun. 02, 2012

Apr. 25, 2012

Mar. 28, 2012

Feb. 27, 2012

Jan. 17, 2012

Feb. 11, 2014

Nov. 08, 2013

Dec. 31, 2012

Dec. 31, 2013

Jul. 02, 2012

Jun. 30, 2012

Sep. 30, 2012

Dec. 31, 2013

Jul. 17, 2013

After Sale of Shares Pursuant to Draw Down Notice [Member]

Warrants Part of Additional Paid in Capital [Member]

Warrants Part of Additional Paid in Capital [Member]

Additional Warrants for Anti-Dilution Impact (Member)

Reduced For Anti-dilution Impact (Member)

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Secured Convertible Promissory [Member]

Secured Convertible Promissory [Member]

Unsecured Bridge Promissory Note [Member]

Unsecured Bridge Promissory Note [Member]

Unsecured Bridge Promissory Note [Member]

Unsecured Bridge Promissory Note [Member]

Unsecured Bridge Promissory Note [Member]

Unsecured Bridge Promissory Note [Member]

Common Stock Purchase Agreement [Member]

Common Stock Purchase Agreement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Visser MTA Agreement [Member]

Visser MTA Agreement [Member]

Liquidmetal Golf [Member]

July 2, 2012 Private Placement [Member]

Common Stock Purchase Agreement [Member]

Convertible Notes Payable [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Visser MTA Agreement [Member]

Visser MTA Agreement [Member]

Private Placement [Member]

Visser MTA Agreement [Member]

Visser MTA Agreement [Member]

Visser MTA Agreement [Member]

Visser MTA Agreement [Member]

Note 3 - Significant Transactions (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$20,000,000

'

'

'

'

'

'

'

Common Stock, Par or Stated Value Per Share (in Dollars per share)

$0.00

$0.00

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock Subscriptions Term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'36 months

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Other (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,666,667

'

'

'

'

'

'

'

Subscription Multiplier For Price Floor

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.775

'

'

'

'

'

'

'

Subscription Floor Price (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.04

'

'

'

'

'

'

'

Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners

'

'

'

'

'

9.99%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock Shares Covered By Registration Statement (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

96,555,893

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, New Issues

12,253,000

13,922,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000,000

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

13,292,020

'

30,000,000

'

'

'

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

'

'

'

'

'

12,000,000

'

2,000,000

'

1,050,000

1,050,000

300,000

350,000

200,000

200,000

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

'

'

'

$0.22

'

'

'

$0.22

'

$0.18

$0.35

$0.08

$0.22

'

'

'

'

'

'

'

'

'

'

$0.08

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

'

'

'

8.00%

'

'

'

'

'

'

'

'

8.00%

'

'

'

'

'

'

'

'

'

Senior Convertible Notes Arithmetic Average Percentage

'

'

'

'

'

'

'

'

'

'

87.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares, Issued (in Shares)

375,707,190

242,074,324

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

163,641,547

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)

29,779,557

29,779,557

'

4,500,000

42,329,407

'

18,750,000

15,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

18,750,000

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)

'

'

'

0.5

0.5

'

0.384

'

18,539,762

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.384

'

'

'

'

Arithmetic average of lowest weighted average prices of common stock

'

'

'

'

'

'

87.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Trading days

'

'

'

'

'

'

'20 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Trading Day Preceding Reset, Date

'

'

'

'

'

'

'2 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale of Stock, Price Per Share (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.10

'

'

'

$0.10

'

'

Proceeds from Issuance of Common Stock

'

3,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000,000

'

'

'

'

'

'

Deferred Finance Costs, Net

0

399,000

'

'

'

'

'

'

'

'

'

'

'

1,355,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Adjustments to Additional Paid in Capital, Warrant Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

2,905,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Price (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.31

'

'

'

Manufacturing Contract Costs (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.21

'

'

'

Operating Expenses

$6,313,000

$12,093,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$6,300,000

'

'

'

Noncontrolling Interest, Ownership Percentage by Parent

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

79.00%

'

Note_4_Liquidity_and_Going_Con1

Note 4 - Liquidity and Going Concern Issues (Details) (USD $)	12 Months Ended							0 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Oct. 31, 2009	2-May-09	Jul. 02, 2012	Jul. 02, 2012	Feb. 11, 2014	Nov. 08, 2013
						Convertible Notes Payable [Member]	Private Placement [Member]	Common Stock Purchase Agreement [Member]	Common Stock Purchase Agreement [Member]
						Private Placement [Member]
Note 4 - Liquidity and Going Concern Issues (Details) [Line Items]	'	'	'	'	'	'	'	'	'
Net Cash Provided by (Used in) Operating Activities	($4,977,000)	($5,173,000)	'	'	'	'	'	'	'
Net Cash Provided by (Used in) Investing Activities	-197,000	-86,000	'	'	'	'	'	'	'
Net Cash Provided by (Used in) Financing Activities	74,000	12,299,000	'	'	'	'	'	'	'
Cash and Cash Equivalents, at Carrying Value	2,062,000	7,162,000	122,000	'	'	'	'	'	'
Debt Instrument, Face Amount	'	'	'	'	'	12,000,000	'	'	'
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)	29,779,557	29,779,557	'	4,500,000	42,329,407	'	18,750,000	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Share)	'	'	'	0.5	0.5	'	0.384	'	'
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors	'	'	'	'	'	'	'	'	20,000,000
Common Stock Subscriptions Term	'	'	'	'	'	'	'	'	'36 months
Common Stock Shares Covered By Registration Statement (in Shares)	'	'	'	'	'	'	'	96,555,893	'
Stock Issued During Period, Value, New Issues	$12,253,000	$13,922,000	'	'	'	'	'	$3,000,000	'
Stock Issued During Period, Shares, New Issues (in Shares)	'	'	'	'	'	'	'	13,292,020	'

Note_5_Trade_accounts_receivab2

Note 5 - Trade accounts receivable (Details) - Trade Acounts Receivable Table (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Trade Acounts Receivable Table [Abstract]	'	'
Trade accounts receivable	$215	$75
Less: Allowance for doubtful accounts	0	-11
Trade accounts receivable, net	$215	$64

Note_6_Prepaid_Expenses_and_Ot1

Note 6 - Prepaid Expenses and Other Current Assets (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Note 6 - Prepaid Expenses and Other Current Assets (Details) [Line Items]	'	'
Prepaid Expense and Other Assets, Current	$412,000	$689,000
Deferred Finance Costs, Net	0	399,000
Amortization of Deferred Charges	360,000	'
Reduction in Balance [Member]	'	'
Note 6 - Prepaid Expenses and Other Current Assets (Details) [Line Items]	'	'
Deferred Finance Costs, Net	0	'
Senior Convertible Notes [Member]	'	'
Note 6 - Prepaid Expenses and Other Current Assets (Details) [Line Items]	'	'
Write off of Deferred Debt Issuance Cost	$39,000	'

Note_7_Property_and_Equipment_1

Note 7 - Property and Equipment (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Abstract]	'	'
Depreciation	$96	$52

Note_7_Property_and_Equipment_2

Note 7 - Property and Equipment (Details) - Property and Equipment (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, And Equipment, Gross	$1,587	$1,406
Accumulated depreciation	-1,338	-1,245
Total property and equipment, net	249	161
Machinery and Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, And Equipment, Gross	1,107	1,098
Computer Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, And Equipment, Gross	203	118
Office Equipment, Furnishings, And Improvements [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, And Equipment, Gross	$277	$190

Note_8_Patents_and_Trademarks_2

Note 8 - Patents and Trademarks, net (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Disclosure Text Block [Abstract]	'	'
Amortization	$118	$137

Note_8_Patents_and_Trademarks_3

Note 8 - Patents and Trademarks, net (Details) - Patents and Trademarks (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'	'
Intangible Assets	$2,369	$2,356
Accumulated amortization	-1,605	-1,487
Total intangible assets, net	764	869
Purchased And Licensed Patent Rights [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Intangible Assets	566	566
Accumulated amortization	-483	-457
Internally Developed Patents [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Intangible Assets	1,664	1,664
Accumulated amortization	-1,022	-937
Trademarks [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Intangible Assets	139	126
Accumulated amortization	($100)	($93)

Note_8_Patents_and_Trademarks_4

Note 8 - Patents and Trademarks, net (Details) - Estimated Future Aggregate Amortization Expense (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Estimated Future Aggregate Amortization Expense [Abstract]	'
2014	$103
2015	97
2016	95
2017	84
2018	83
Thereafter	$302

Note_8_Patents_and_Trademarks_5

Note 8 - Patents and Trademarks, net (Details) - Accumulated Amortization (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Note 8 - Patents and Trademarks, net (Details) - Accumulated Amortization [Line Items]	'	'
Accumulated Amortization	($1,605)	($1,487)
Purchased And Licensed Patent Rights [Member]	'	'
Note 8 - Patents and Trademarks, net (Details) - Accumulated Amortization [Line Items]	'	'
Accumulated Amortization	-483	-457
Internally Developed Patents [Member]	'	'
Note 8 - Patents and Trademarks, net (Details) - Accumulated Amortization [Line Items]	'	'
Accumulated Amortization	-1,022	-937
Trademarks [Member]	'	'
Note 8 - Patents and Trademarks, net (Details) - Accumulated Amortization [Line Items]	'	'
Accumulated Amortization	($100)	($93)

Note_8_Patents_and_Trademarks_6

Note 8 - Patents and Trademarks, net (Details) - Weighted Average Amortization Periods	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Purchased And Licensed Patent Rights [Member]	'	'
Note 8 - Patents and Trademarks, net (Details) - Weighted Average Amortization Periods [Line Items]	'	'
Weighted Average Amortization Periods	'17 years	'17 years
Internally Developed Patents [Member]	'	'
Note 8 - Patents and Trademarks, net (Details) - Weighted Average Amortization Periods [Line Items]	'	'
Weighted Average Amortization Periods	'17 years	'17 years
Trademarks [Member]	'	'
Note 8 - Patents and Trademarks, net (Details) - Weighted Average Amortization Periods [Line Items]	'	'
Weighted Average Amortization Periods	'10 years	'10 years

Note_9_Other_LongTerm_Liabilit1

Note 9 - Other Long-Term Liabilities (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]	'	'
Other Liabilities, Noncurrent	$856	$856
Period for outstanding liability	'5 years	'

Note_10_ShortTerm_Debt_Details

Note 10 - Short-Term Debt (Details) (USD $)

0 Months Ended

12 Months Ended

12 Months Ended

Jul. 11, 2012

Apr. 06, 2011

Aug. 06, 2010

Dec. 31, 2013

Dec. 31, 2012

Oct. 10, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Jun. 02, 2012

Apr. 25, 2012

Mar. 28, 2012

Feb. 27, 2012

Jan. 17, 2012

SAGA Promissory Note [Member]

Promissory Note [Member]

Promissory Note [Member]

Unsecured Bridge Promissory Note [Member]

Unsecured Bridge Promissory Note [Member]

Unsecured Bridge Promissory Note [Member]

Unsecured Bridge Promissory Note [Member]

Unsecured Bridge Promissory Note [Member]

Unsecured Bridge Promissory Note [Member]

Unsecured Bridge Promissory Note [Member]

Note 10 - Short-Term Debt (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss Contingency, Damages Sought, Value

'

'

$3,200,000

'

'

'

'

'

'

'

'

'

'

'

'

Litigation Settlement, Amount

1,743,000

2,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Restricted Shares Issued For Legal Settlement (in Shares)

'

4,496,429

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

1,712,000

'

'

'

1,050,000

1,050,000

300,000

350,000

200,000

200,000

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

8.00%

'

'

'

'

'

'

'

'

8.00%

Interest Expense

'

'

'

$245,000

$459,000

'

$0

$68,000

$0

$18,000

'

'

'

'

'

Note_11_Convertible_Notes_Embe2

Note 11 - Convertible Notes, Embedded Conversion Feature Liability, and Gain on Extinguishment of Debt (Details) (USD $)	1 Months Ended	0 Months Ended	12 Months Ended				12 Months Ended	13 Months Ended		12 Months Ended
In Thousands, except Share data, unless otherwise specified	Jul. 17, 2013	Jul. 02, 2012	Dec. 31, 2013	Dec. 31, 2012	Oct. 31, 2009	Jul. 02, 2012	Dec. 31, 2013	Jul. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Jul. 02, 2012
						Convertible Notes Payable [Member]	Convertible Notes Payable [Member]	Convertible Notes Payable [Member]	Convertible Notes Payable [Member]	Private Placement [Member]	Private Placement [Member]
						Private Placement [Member]
Note 11 - Convertible Notes, Embedded Conversion Feature Liability, and Gain on Extinguishment of Debt (Details) [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Debt Instrument, Face Amount	'	'	'	'	'	$12,000	'	'	'	'	'
Debt Instrument, Convertible, Conversion Price (in Dollars per share)	'	'	'	'	$0.22	$0.35	'	$0.08	'	$0.08	'
Debt Instrument, Interest Rate, Stated Percentage	'	'	'	'	'	8.00%	'	'	'	'	'
Embedded Derivatives Addition Original Valuation	'	'	'	'	'	'	'	'	'	'	8,865
Warrants and Rights Outstanding	'	'	4,921	2,766	'	'	'	'	'	'	5,053
Embedded Conversion Feature Liability And Warrants	'	'	'	'	'	'	'	'	'	'	13,918
Debt Instrument, Unamortized Discount	'	12,000	'	'	'	'	'	'	-4,635	'	'
Change in face value of the embedded conversion feature liability and warrants	'	1,918	'	'	'	'	'	'	'	'	'
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares)	'	'	'	'	'	'	'	163,641,547	'	'	'
Debt Instrument, Periodic Payment	'	'	'	'	'	'	7,000	12,000	'	'	'
Debt Instrument, Periodic Payment, Interest	'	'	'	'	'	'	'	680	'	'	'
Interest Expense, Debt	'	'	'	'	'	'	242	'	'	'	'
Convertible Debt	'	'	'	2,365	'	'	0	'	2,365	'	'
Debt Conversion, Original Debt, Amount	12,000	'	'	'	'	'	'	'	'	'	'
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	18,679,584	'	'	'	'	'	'	'	'	163,641,547	'
Gains (Losses) on Extinguishment of Debt	$91	'	$91	'	'	'	'	'	'	'	'

Note_11_Convertible_Notes_Embe3

Note 11 - Convertible Notes, Embedded Conversion Feature Liability, and Gain on Extinguishment of Debt (Details) - Convertible Note, Net of Debt Discount (USD $)	12 Months Ended			12 Months Ended	13 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Jul. 02, 2012	Dec. 31, 2013	Jul. 31, 2013
				Convertible Notes Payable [Member]	Convertible Notes Payable [Member]
Note 11 - Convertible Notes, Embedded Conversion Feature Liability, and Gain on Extinguishment of Debt (Details) - Convertible Note, Net of Debt Discount [Line Items]	'	'	'	'	'
Convertible Note	'	'	'	$7,000	'
Debt Discount	'	'	12,000	-4,635	'
Net Total	2,365	'	'	2,365	'
Installment Payments in Shares	'	'	'	-7,000	-12,000
Amortization	6,504	11,949	'	4,181	'
Write-off associated with convertible debt extinguishment	'	'	'	454	'
Debt Discount	'	'	12,000	'	'
Net Total	'	$2,365	'	$0	'

Note_12_Warrant_Liabilities_De

Note 12 - Warrant Liabilities (Details) (USD $)

12 Months Ended

0 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

In Thousands, except Share data, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Oct. 31, 2009

2-May-09

Jul. 02, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Visser MTA Agreement [Member]

Visser MTA Agreement [Member]

Visser MTA Agreement [Member]

Warrants Valued As Liability [Member]

Warrants Valued As Liability [Member]

Note 12 - Warrant Liabilities (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)

29,779,557

29,779,557

4,500,000

42,329,407

18,750,000

'

'

'

15,000,000

18,562,825

15,776,632

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Share)

'

'

0.5

0.5

0.384

'

'

'

0.22

0.18

0.21

'

'

Original valuation - June & July 2012

'

'

'

'

$5,053

'

'

'

$4,260

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)

'

'

0.5

0.5

0.384

'

'

'

0.22

0.18

0.21

'

'

Warrants That Were Exercised

'

'

'

'

'

2,362

'

'

'

2,559

'

'

'

Fair Value Assumptions, Expected Term

'

'

'

'

'

'3 years 6 months

'

'

'

'3 years 153 days

'

'

'

Fair Value Assumptions, Expected Volatility Rate

'

'

'

'

'

143.00%

'

'

'

142.00%

'

'

'

Fair Value Assumptions, Risk Free Interest Rate

1.75%

0.72%

'

'

'

1.75%

'

'

'

1.75%

'

'

'

Fair Value Assumptions, Expected Dividend Rate

0.00%

0.00%

'

'

'

0.00%

'

'

'

0.00%

'

'

'

Gain (Loss) in Value of Warrants

-2,155

6,547

'

'

'

'

-856

3,547

'

-1,299

3,000

'

'

Class of Warrant or Right, Outstanding (in Shares)

67,092,382

63,529,557

'

'

'

'

'

'

'

'

'

-37,312,825

33,750,000

Warrants and Rights Outstanding

$4,921

$2,766

'

'

$5,053

'

'

'

'

$2,559

$1,260

$4,921

$2,766

Note_12_Warrant_Liabilities_De1

Note 12 - Warrant Liabilities (Details) - Summary of Changes In The Warrant Liability (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Class of Warrant or Right [Line Items]	'	'
Balance	$2,766	'
Change in value of warrant liability, loss	2,155	-6,547
Balance	4,921	2,766
Visser MTA Agreement [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Balance	1,260	'
Change in value of warrant liability, loss	1,299	-3,000
Balance	2,559	1,260
July 2, 2012 Private Placement [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Balance	1,506	'
Change in value of warrant liability, loss	856	'
Balance	$2,362	'

Note_12_Warrant_Liabilities_De2

Note 12 - Warrant Liabilities (Details) - Fair Value Assumptions Used To Determine The Value of Warrants Outstanding	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Note 12 - Warrant Liabilities (Details) - Fair Value Assumptions Used To Determine The Value of Warrants Outstanding [Line Items]	'	'
Risk-free interest rate	1.75%	0.72%
Dividend rate	0.00%	0.00%
Minimum [Member]	'	'
Note 12 - Warrant Liabilities (Details) - Fair Value Assumptions Used To Determine The Value of Warrants Outstanding [Line Items]	'	'
Expected life in years	'3 years 153 days	'4 years 153 days
Volatility	142.00%	151.00%
Maximum [Member]	'	'
Note 12 - Warrant Liabilities (Details) - Fair Value Assumptions Used To Determine The Value of Warrants Outstanding [Line Items]	'	'
Expected life in years	'3 years 6 months	'4 years 6 months
Volatility	143.00%	152.00%

Note_12_Warrant_Liabilities_De3

Note 12 - Warrant Liabilities (Details) - Outstanding Warrants To Acquire Shares Of The Common Stock	Dec. 31, 2013	Dec. 31, 2012	Oct. 31, 2009	2-May-09	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
					Warrant 1 [Member]	Warrant 2 [Member]	Warrant 3 [Member]	Warrant 4 [Member]
Class of Warrant or Right [Line Items]	'	'	'	'	'	'	'	'
Number of Shares	67,092,382	63,529,557	'	'	208,334	29,571,223	18,562,825	18,750,000
Exercise Price (in Dollars per Item)	'	'	0.5	0.5	0.48	0.49	0.178	0.384
Expiration Date	'	'	'	'	15-Jul-15	15-Jul-15	1-Jun-17	2-Jul-17

Note_13_Shareholders_Equity_De1

Note 13 - Shareholders' Equity (Deficit) (Details) (USD $)

1 Months Ended

12 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

0 Months Ended

1 Months Ended

12 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

In Thousands, except Share data, unless otherwise specified

Jul. 17, 2013

Dec. 31, 2013

Oct. 24, 2013

Feb. 28, 2013

Feb. 27, 2013

Dec. 31, 2012

Oct. 31, 2009

2-May-09

Oct. 31, 2009

2-May-09

Dec. 31, 2013

Jun. 30, 2012

Dec. 31, 2013

Jul. 02, 2012

Feb. 11, 2014

Nov. 08, 2013

Feb. 27, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

2-May-09

Oct. 31, 2009

Dec. 31, 2012

2-May-09

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Reduced For Anti-dilution Impact (Member)

Reduced For Anti-dilution Impact (Member)

Senior Convertible Notes [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Common Stock Purchase Agreement [Member]

Common Stock Purchase Agreement [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Convertible Series A1 Preferred Stock [Member]

Convertible Series A1 Preferred Stock [Member]

Convertible Series A1 Preferred Stock [Member]

Convertible Series A2 Preferred Stock [Member]

Convertible Series A2 Preferred Stock [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Private Placement [Member]

Visser MTA Agreement [Member]

Note 13 - Shareholders' Equity (Deficit) (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

'

'

'

'

'

'

'

'

'

30,000,000

'

'

13,292,020

'

'

116,136,796

80,171,418

'

'

500,000

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Shares Issued

18,679,584

'

'

'

'

'

'

'

'

'

'

'

163,641,547

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

'

'

'

'

'

'

$0.22

'

'

'

'

'

$0.08

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.10

'

$0.22

Debt Instrument, Periodic Payment, Principal (in Dollars)

'

'

'

'

'

'

'

'

'

'

$12,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Periodic Payment, Interest (in Dollars)

'

'

'

'

'

'

'

'

'

'

680

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion of Stock, Shares Converted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

506,936

792,215

'

'

'

'

'

'

'

'

'

Conversion of Stock, Shares Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,626,840

16,896,070

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares Authorized

'

700,000,000

700,000,000

500,000,000

400,000,000

700,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Other

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,666,667

'

'

'

'

'

'

180,000

'

2,625,000

'

'

'

'

'

Share Price (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$5

'

'

$5

'

'

'

'

'

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

'

29,779,557

'

'

'

29,779,557

4,500,000

42,329,407

'

'

'

'

'

18,750,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)

'

'

'

'

'

'

0.5

0.5

'

'

'

'

'

0.384

'

'

'

'

'

'

'

'

'

'

'

'

0.48

'

0.49

'

Class of warrant or right adjusted exercise price of warrants or rights (in Dollars per Item)

'

'

'

'

'

'

'

'

0.49

0.49

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible preferred stock conversion price (in Dollars per share)

'

'

'

'

'

$0.10

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Share)

'

'

'

'

'

'

0.5

0.5

'

'

'

'

'

0.384

'

'

'

'

'

'

'

'

'

'

'

'

0.48

'

0.49

'

Convertible Preferred Stock, Shares Issued upon Conversion

'

16,896,070

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25,669,752

'

'

'

'

'

'

'

'

16,896,073

'

'

Preferred Stock, Shares Outstanding

'

0

'

'

'

506,936

'

'

'

'

'

'

'

'

'

'

'

'

'

'

506,936

'

'

105,231

'

401,705

'

'

'

'

Preferred Stock, Value, Issued (in Dollars)

'

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Dividends Payable (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

222

'

'

'

'

'

'

'

'

'

Adjustments to Additional Paid in Capital, Reclassification of Accrued Preferred Stock Dividends (in Dollars)

'

222

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Classified Equity (in Dollars)

'

'

'

'

'

$18,179

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note_14_Stock_Compensation_Pla2

Note 14 - Stock Compensation Plan (Details) (USD $)	12 Months Ended			12 Months Ended	0 Months Ended	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2010	Dec. 31, 2013	Aug. 03, 2010	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2013
				Employee Stock Option [Member]	Restricted Stock [Member]	Restricted Stock [Member]	Restricted Stock [Member]	2002 Equity Incentive Plan [Member]	Equity Incentive Plan 2012 [Member]
				Equity Incentive Plan 2012 [Member]	Chief Executive Officer [Member]	Chief Executive Officer [Member]	Chief Executive Officer [Member]
Note 14 - Stock Compensation Plan (Details) [Line Items]	'	'	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	'	'	'	'	'	'	'	10,000,000	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	15,734,500	3,722,000	4,679,807	13,127,500	'	'	'	2,607,000	'
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	'	'	'	'	'	'	'	'	30,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	13,317,500	330,000	'	13,317,500	'	'	'	'	'
Allocated Share-based Compensation Expense (in Dollars)	$525	$363	'	'	'	'	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)	487	113	'	'	'	'	'	'	'
Deferred Compensation Arrangement with Individual, Shares Issued	'	'	'	'	6,000,000	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	'	'	'	'	'5 years	'	'	'	'
Deferred Compensation Arrangement with Individual, Compensation Expense (in Dollars)	'	'	'	'	'	$312	$310	'	'
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rates Minimum	28.30%	'	'	'	'	'	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rates Maximum	'	28.30%	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value (in Dollars per share)	$0.11	$0.08	'	'	'	'	'	'	'

Note_14_Stock_Compensation_Pla3

Note 14 - Stock Compensation Plan (Details) - Assumptions Used To Estimate Fair Value	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Note 14 - Stock Compensation Plan (Details) - Assumptions Used To Estimate Fair Value [Line Items]	'	'
Expected term (in years)	'	'6 years 6 months
Minimum [Member]	'	'
Note 14 - Stock Compensation Plan (Details) - Assumptions Used To Estimate Fair Value [Line Items]	'	'
Expected volatility	128.55%	140.74%
Expected term (in years)	'6 years 116 days	'
Risk-free rate	1.26%	0.98%
Maximum [Member]	'	'
Note 14 - Stock Compensation Plan (Details) - Assumptions Used To Estimate Fair Value [Line Items]	'	'
Expected volatility	168.09%	143.23%
Expected term (in years)	'9 years 222 days	'
Risk-free rate	2.49%	1.04%

Note_14_Stock_Compensation_Pla4

Note 14 - Stock Compensation Plan (Details) - Summary of Stock Option Transactions (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2010
Summary of Stock Option Transactions [Abstract]	'	'	'
Number of Shares	3,722,000	'	4,679,807
Weighted Average Exercise Price (in Dollars per share)	$0.36	'	$0.42
Weighted Average Remaining Contractual Term	'8 years 146 days	'	'
Aggregate Intrinsic Value (in Dollars)	$1,155	'	'
Options exercisable at December 31, 2013	1,677,000	'	'
Options exercisable at December 31, 2013 (in Dollars per share)	$0.45	'	'
Options exercisable at December 31, 2013	'3 years 219 days	'	'
Options exercisable at December 31, 2013 (in Dollars)	38	'	'
Options unvested at December 31, 2013	14,057,500	'	'
Options unvested at December 31, 2013 (in Dollars per share)	$0.09	'	'
Options unvested at December 31, 2013	'8 years 328 days	'	'
Options unvested at December 31, 2013 (in Dollars)	1,117	'	'
Options vested or expected to vest at December 31, 2013	10,174,928	'	'
Options vested or expected to vest at December 31, 2013 (in Dollars per share)	$0.15	'	'
Options vested or expected to vest at December 31, 2013	'8 years	'	'
Options vested or expected to vest at December 31, 2013 (in Dollars)	$714	'	'
Number of Shares	13,317,500	330,000	'
Weighted Average Exercise Price (in Dollars per share)	$0.08	$0.28	'
Number of Shares	-600,000	-354,000	'
Weighted Average Exercise Price (in Dollars per share)	$0.12	$0.12	'
Number of Shares	-605,000	-396,200	'
Weighted Average Exercise Price (in Dollars per share)	$0.20	$0.31	'
Number of Shares	-100,000	-537,607	'
Weighted Average Exercise Price (in Dollars per share)	$2.49	$1	'
Number of Shares	15,734,500	3,722,000	4,679,807
Weighted Average Exercise Price (in Dollars per share)	$0.13	$0.36	$0.42

Note_14_Stock_Compensation_Pla5

Note 14 - Stock Compensation Plan (Details) - Summary of Stock Options Outstanding And Exercisable by Ranges of Option Prices (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options outstanding, numbers of options outstanding (in Shares)	15,734,500
Options exercisable, number of options exercisable (in Shares)	1,677,000
$0.00 - 0.10 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of exercise prices, lower range limit	$0
Range of exercise prices, upper range limit	$0.10
Options outstanding, numbers of options outstanding (in Shares)	12,717,500
Options outstanding, weighted average remaining contractual life	'9 years 14 days
Options outstanding, weighted average exercise price	$0.08
Options exercisable, number of options exercisable (in Shares)	200,000
Options exercisable, weighted average remaining contractual life	'4 years 335 days
Options exercisable, weighted average exercise price	$0.09
$0.11 - 2.33 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of exercise prices, lower range limit	$0.11
Range of exercise prices, upper range limit	$2.33
Options outstanding, numbers of options outstanding (in Shares)	3,017,000
Options outstanding, weighted average remaining contractual life	'5 years 219 days
Options outstanding, weighted average exercise price	$0.32
Options exercisable, number of options exercisable (in Shares)	1,477,000
Options exercisable, weighted average remaining contractual life	'3 years 160 days
Options exercisable, weighted average exercise price	$0.50

Note_15_Income_Taxes_Details

Note 15 - Income Taxes (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Note 15 - Income Taxes (Details) [Line Items]	'	'
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	34.00%	34.00%
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	$0	$0
Domestic Tax Authority [Member] | Liquidmetal Golf, Inc [Member]	'	'
Note 15 - Income Taxes (Details) [Line Items]	'	'
Operating Loss Carryforwards	35,900,000	'
Domestic Tax Authority [Member] | Research Tax Credit Carryforward [Member]	'	'
Note 15 - Income Taxes (Details) [Line Items]	'	'
Tax Credit Carryforward, Amount	189,000	243,000
Domestic Tax Authority [Member]	'	'
Note 15 - Income Taxes (Details) [Line Items]	'	'
Operating Loss Carryforwards	$126,600,000	'

Note_15_Income_Taxes_Details_S

Note 15 - Income Taxes (Details) - Significant Components of Deferred Tax Assets (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Significant Components of Deferred Tax Assets [Abstract]	'	'
Loss carry forwards	$50,165	$60,426
Debt Discount	891	-1,523
NQSO	628	422
Tax Credits	431	432
Other	259	120
Total deferred tax asset	52,374	59,877
Valuation allowance	($52,374)	($59,877)

Note_15_Income_Taxes_Details_D

Note 15 - Income Taxes (Details) - Differences Between The Expected Federal Tax Benefit And Actual Tax Provision	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Differences Between The Expected Federal Tax Benefit And Actual Tax Provision [Abstract]	'	'
Expected federal tax benefit	-34.00%	-34.00%
Permanent items	0.10%	0.10%
Net operating loss utilized or expired	0.00%	5.50%
Increase in valuation allowance and others	33.90%	28.40%
Total deferred tax asset	0.00%	0.00%

Note_16_Loss_Per_Common_Share_

Note 16 - Loss Per Common Share (Details) (USD $)

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2010

Oct. 31, 2009

2-May-09

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Options [Member]

Options [Member]

Options [Member]

Options [Member]

Options [Member]

Options [Member]

Warrant [Member]

Warrant [Member]

Warrant [Member]

Warrant [Member]

Warrant [Member]

Warrant [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Note 16 - Loss Per Common Share (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)

'

'

'

'

'

15,734,500

3,722,000

'

'

'

'

67,092,382

63,529,557

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$0.13

$0.36

$0.42

'

'

'

'

$0.08

$0.09

$2.33

$5

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)

'

'

'

0.5

0.5

'

'

'

'

'

'

'

'

0.18

0.22

0.49

0.49

0.48

'

0.49

'

Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)

16,896,070

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

16,896,073

'

'

Debt Instrument, Convertible, Conversion Price

'

'

'

$0.22

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.10

'

$0.22

Note_17_Commitments_and_Contin2

Note 17 - Commitments and Contingencies (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Commitments and Contingencies Disclosure [Abstract]	'	'
Deferred Costs, Leasing, Net, Current	$39	$28
Operating Leases, Rent Expense, Net	$200	$214

Note_17_Commitments_and_Contin3

Note 17 - Commitments and Contingencies (Details) - Future Minimum Lease Payments Under Non-Cancelable Operating Leases During Subsequent Years (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Future Minimum Lease Payments Under Non-Cancelable Operating Leases During Subsequent Years [Abstract]	'
2014	$210
2015	217
2016	73
Total	$500

Note_18_401k_Savings_Plan_Deta

Note 18 - 401(k) Savings Plan (Details)	12 Months Ended
	Dec. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent	15.00%

Note_19_Related_Party_Transact1

Note 19 - Related Party Transactions (Details) (USD $)

12 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

12 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

In Thousands, except Share data, unless otherwise specified

Dec. 31, 2012

Aug. 03, 2013

Jun. 13, 2013

Feb. 28, 2013

Aug. 05, 2013

Feb. 02, 2012

Feb. 27, 2013

Dec. 31, 2013

Feb. 28, 2013

Feb. 27, 2013

Feb. 02, 2012

Feb. 28, 2013

Feb. 27, 2013

Aug. 05, 2011

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Aug. 05, 2012

Oct. 14, 2010

Dec. 31, 2013

Dec. 31, 2012

Feb. 28, 2013

Dec. 31, 2013

Dec. 31, 2013

Restricted Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Convertible Series A1 Preferred Stock [Member]

Convertible Series A1 Preferred Stock [Member]

Convertible Series A1 Preferred Stock [Member]

Convertible Series A2 Preferred Stock [Member]

Convertible Series A2 Preferred Stock [Member]

Innovative Materials Group [Member]

Innovative Materials Group [Member]

Innovative Materials Group [Member]

Innovative Materials Group [Member]

Innovative Materials Group [Member]

Innovative Materials Group [Member]

James Kang [Member]

James Kang [Member]

Board of Directors Chairman [Member]

Chief Executive Officer [Member]

Visser [Member]

Chief Executive Officer [Member]

Chief Financial Officer [Member]

Board of Directors Chairman [Member]

Chief Executive Officer [Member]

Chief Financial Officer [Member]

Board of Directors Chairman [Member]

Mr. Chitayat [Member]

Chief Financial Officer [Member]

Board of Directors Chairman [Member]

Mr. Chitayat [Member]

Note 19 - Related Party Transactions (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related Party Deposit Liabilities (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$520

'

'

'

'

'

Sale of Stock, Consideration Received on Transaction (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

720

'

'

'

'

'

'

'

'

'

'

Notes, Loans and Financing Receivable, Gross, Current (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

200

200

'

200

'

'

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8.00%

'

'

'

'

'

'

Royalty Revenue (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8

26

'

'

'

'

'

'

'

Debt Instrument, Increase, Accrued Interest (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

21

'

'

'

'

'

'

'

'

'

Fair Value of Assets Acquired (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

221

'

'

'

'

'

'

'

'

'

Impairment of Long-Lived Assets Held-for-use (in Dollars)

221

'

'

'

'

'

'

'

'

'

'

'

'

'

221

'

'

'

'

'

'

'

'

'

Legal Fees (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0

$2

'

'

'

Conversion of Stock, Shares Converted

'

'

'

'

'

'

'

'

58,600

28,928

10,000

260,710

109,528

'

'

'

'

'

'

'

'

'

'

'

Conversion of Stock, Shares Issued

'

'

'

10,387,883

'

565,344

4,626,840

16,896,070

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale of Stock, Number of Shares Issued in Transaction

'

'

1,324,999

'

400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale of Stock, Price Per Share (in Dollars per share)

'

'

$0.08

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage Of Beneficial Ownership Held In The Entity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5.00%

'

5.00%

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

'

1,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Future Sale of Common Stock by Stock Holders, Shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

400,000

'